US20100189863A1 - Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances - Google Patents

Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances Download PDF

Info

Publication number
US20100189863A1
US20100189863A1 US12/445,842 US44584207A US2010189863A1 US 20100189863 A1 US20100189863 A1 US 20100189863A1 US 44584207 A US44584207 A US 44584207A US 2010189863 A1 US2010189863 A1 US 2010189863A1
Authority
US
United States
Prior art keywords
formula
compound
atoms
carboxylic acid
dimethylbutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US12/445,842
Other versions
US8487133B2 (en
Inventor
Jan Looft
Tobias Vössing
Michael Backes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise AG filed Critical Symrise AG
Priority to US12/445,842 priority Critical patent/US8487133B2/en
Assigned to SYMRISE GMBH & CO. KG reassignment SYMRISE GMBH & CO. KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOOFT, JAN, BACKES, MICHAEL, VOSSING, TOBIAS
Publication of US20100189863A1 publication Critical patent/US20100189863A1/en
Assigned to SYMRISE AG reassignment SYMRISE AG MERGER (SEE DOCUMENT FOR DETAILS). Assignors: SYMRISE GMBH & CO. KG
Application granted granted Critical
Publication of US8487133B2 publication Critical patent/US8487133B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L23/00Soups; Sauces; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20Synthetic spices, flavouring agents or condiments
    • A23L27/205Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • A23L27/63Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/88Taste or flavour enhancing agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/20All rings being cycloaliphatic the ring system containing seven carbon atoms

Definitions

  • the present invention relates to the use of specific substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides and specific derivatives thereof of the Formula (I) (see below) as food flavor substances (taste substances).
  • the compounds are suitable in particular for producing, modifying or intensifying an umami flavor.
  • the invention relates furthermore to specific compositions and semi-finished products which contain a flavor-imparting effective amount of the aforementioned compounds of the Formula (I), as well as specific methods for producing, modifying and/or intensifying specific flavor impressions, in particular the umami taste.
  • the invention also relates to new compounds of the Formula (I) (see below) that impart special flavor impressions.
  • many important cooling substances such as WS3, WS5 and WS23 have an amide structure:
  • Sensorially important amides also include the hot-tasting substances capsaicin from chili pods and the piperin of white pepper.
  • the naturally occurring alkamides pellitorin and spilanthol have, apart from a saliva-generating and tingling action, also a long-lasting and numbing effect in the mouth:
  • PhHN P. Besinet et al., Bulletin de la Societe Chimique de France (1969), 1377-1381. PhHN— Max Mousseron, Compt. rend. (1956), 243, 1880-1882.
  • Me denotes methyl
  • Et denotes ethyl
  • Ph denotes phenyl
  • WO 2004/032716 Modulation of cholesterol transport by regulating the HDL Scavenger Receptor SR-BI.
  • WO 2005/007141 Inhibitors of the POSH ubiquitin ligase for the treatment of neurological and viral diseases and cancer.
  • US 2004/209859 discloses the use of di-substituted and tri-substituted bicyclo[4.1.0]heptane-7-carboxylic acid derivatives as anticonvulsive compounds used inter alia for the treatment of migraine, epilepsy or dipolar disorders.
  • A denotes cycloalkyl or bicycloalkyl Ra, Rb, Rc denote independently of one another H or alkyl
  • R1 denotes OR2 or NR3R4 where R2 denotes H or alkyl, and R3, R4 independently of one another denote for example H, alkyl or alkenyl.
  • a first aspect of the present invention therefore relates to the use of a compound of the Formula (I)
  • R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms, with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least a further one of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms; Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl, preferably hydrogen or methyl, particularly preferably both denote hydrogen; and Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6
  • the total number of carbon atoms of a compound of the Formula (I) used according to the invention is preferably not greater than 25, preferably not greater than 20.
  • the compound of the Formula (I) comprises in each case hydrogen as radicals R2, R4, R6 and R8 and is thus a compound of the Formula (II)
  • R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms, with the proviso that at least 1 of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen, wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms, Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl, and Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
  • a compound of the Formula (I) (preferably of the Formula (II)), in particular one of the preferred compounds described above and hereinafter, for producing, modifying or intensifying an umami taste.
  • the cyclopropanecarboxylic acid ethylamide not according to the invention and illustrated hereinafter has, as our own investigations have shown, a very weak umami taste at concentrations of 10 ppm in aqueous solutions.
  • the unsubstituted bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide not according to the invention has no detectable taste (the following drawing shows the numbering of the positions on the basic skeleton):
  • the 2,4-dimethyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide according to the invention also has, like the just discussed mono alkyl-substituted compound, a slight salt-intensifying effect, but on the other hand has a stronger, umami-like intrinsic taste:
  • R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms, or
  • R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms, wherein in Formula (III) and Formula (IV): Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
  • R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV) denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl
  • Ra and Rb independently of one another denote hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl
  • Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • Ra denotes hydrogen and Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-eth
  • Tricyclo[3.2.1.02,4]octane-3-carboxylic acid ethylamide has a distinct umami taste and a salt-intensifying effect. In sensorial tests a statistically significant increase in the mouthfeel is found already at concentrations of 50 ppm in broths/consommés made from American beef extract:
  • This compound of the Formula (IVc) also intensifies the saltiness, the sweetness and the umami taste of aroma compositions.
  • a trained panel found, again in a statistically significant manner, that simply by adding 5 ppm of the compound to 0.5 wt. % of American beef bouillon, the mouthfeel is increased by roughly the same extent as is normally achieved only by the addition of 0.05 wt. % of MSG.
  • compositions in particular compositions suitable for consumption, including or consisting of a flavor-effective amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as well as one or more further constituents (ingredients) suitable for consumption.
  • a flavor-effective amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as well as one or more further constituents (ingredients) suitable for consumption.
  • the compounds of the Formula (I) used according to the invention and contained in the composition which is preferably a compound of the Formula (II), (III) or (IV)
  • the comments made above apply as appropriate.
  • compositions used for nutritional, oral hygiene or consumption purposes are normally products that are intended to be ingested orally, where they remain in the mouth for a certain time and are then either consumed (for example foodstuffs ready for consumption, see also hereinafter) or are removed from the mouth (for example chewing gums or toothpastes).
  • These products thus include all substances or preparations that are intended to be ingested in the processed, partially processed or unprocessed state by humans.
  • These products in addition also include substances that are added to foodstuffs in the course of their preparation, processing or treatment and are accordingly intended to be ingested by humans.
  • foodstuffs are understood in particular to be substances which are intended to be swallowed in the unaltered, prepared or processed state by humans and then digested; foodstuffs are also understood to include coatings, coverings or other types of enclosures which are intended to be swallowed at the same time, or in which swallowing is envisaged. Also, certain products that are normally removed from the mouth (e.g. chewing gums) are understood to be foodstuffs within the context of the present specification, since it is not out of the question that they are at least partially swallowed.
  • a foodstuff that is ready for consumption is understood in this connection to mean a foodstuff that is already fully formulated as regards the substances important for the taste and flavor.
  • the term “foodstuff ready for consumption” also includes beverages, drinks as well as solid or semi-solid foodstuffs ready for consumption. Examples that may be mentioned include deepfrozen products that have to be defrosted before consumption and heated to the consumption temperature. Also, products such as yoghurt or ice-cream and also chewing gum or hard caramels are included as foodstuffs ready for consumption.
  • a mouth care product within the context of the invention is one of the formulations known to the person skilled in the art for cleaning and care of the oral cavity and throat and also for freshening the breath.
  • Dental care and gum care is specifically included in this connection.
  • Application forms of conventional oral hygiene formulations are in particular to pills, gels, pastes, foams, emulsions, suspensions, aerosols, sprays as well as capsules, granules, pastilles, tablets, sweets or chewing gum, though this list should not be understood as limiting for the purposes of the present invention.
  • mouthcare products are in particular those in the form of toothpastes, dental crmes, dental gels, dental powders, dental cleaning liquids, dental cleaning foams, mouthwashes, dental crmes and mouthwashes as two-in-one products, lollypops, mouth sprays, flossing agents or dental chewing gums.
  • Chewing gums include in general a chewing gum base, i.e. a chewing composition that becomes plastic on chewing, sugars of various types, sugar substitutes, other sweeteners, sugar alcohols (in particular sorbitol, xylitol, manitol), cooling substances, taste corrigents for unpleasant taste impressions, further taste-altering substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypropionic acid), humectants, thickening agents, emulsifiers, stabilizers, odor corrigents and aroma substances (e.g.: eucalyptus-menthol, cherry, strawberry, grapefruit, vanilla, banana, citrus fruits, peach, blackcurrant, tropical fruits, ginger, coffee, cinnamon, combinations (of the aforementioned aroma substances) with mint aromas such as spearmint and peppermint alone).
  • elastomers such as polyvinyl acetates (PVA), polyethylenes, (low molecular weight or medium molecular weight) polyisobutenes (PIB), polybutadienes, isobutene-isoprene copolymers (butyl rubber), polyvinyl ethyl ether (PVE), polyvinyl butyl ether, copolymers of vinyl esters and vinyl ethers, styrene-butadiene copolymers (styrene-butadiene rubber, SBR) or vinyl elastomers, for example based on vinyl acetate/vinyl laurate, vinyl acetate
  • PVA polyvinyl acetates
  • PIB low molecular weight or medium molecular weight
  • PVE polyvinyl ethyl ether
  • SBR styrene-butadiene rubber
  • vinyl elastomers for example based on vinyl acetate/vinyl la
  • chewing gum bases include further constituents such as for example (mineral) fillers, plasticizers, emulsifiers, antioxidants, waxes, fats or fatty oils, such as for example hardened (hydrogenated) vegetable or animal fats, and monoglycerides, diglycerides or triglycerides.
  • constituents such as for example (mineral) fillers, plasticizers, emulsifiers, antioxidants, waxes, fats or fatty oils, such as for example hardened (hydrogenated) vegetable or animal fats, and monoglycerides, diglycerides or triglycerides.
  • Suitable (mineral) fillers are for example calcium carbonate, titanium dioxide, silicon dioxide, talcum, aluminium oxide, dicalcium phosphate, tricalcium phosphate, magnesium hydroxide and their mixtures.
  • Suitable plasticizers and agents for preventing agglutination (detackifiers) are for example lanolin, stearic acid, sodium stearate, ethyl acetate, diacetin (glycerol diacetate), triacetin (glycerol triacetate), triethyl citrate.
  • Suitable waxes are for example paraffin waxes, candelilla wax, carnauba wax, microcrystalline waxes and polyethylene waxes.
  • Suitable emulsifiers are for example phosphatides such as lecithin, monoglycerides and diglycerides of fatty acids, e.g. glycerol monostearate.
  • compositions according to the invention are preferred. Particularly preferred is a (preferably spray-dried) composition which includes, in addition to one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, also one or more solid carrier substances suitable for consumption. Preferred compositions consist of the compound or compounds of the Formulae (I), (II), (III) or (IV) used according to the invention as well as the carrier substance or substances.
  • Advantageous carrier substances in these preferred (preferably spray-dried) compositions according to the invention are silicon dioxide (silicic acid, silica gel), carbohydrates and/or carbohydrate polymers (polysaccharides), cyclodextrins, starches, degraded starches (starch hydrolysates), chemically or physically modified starches, modified celluloses, gum Arabic, ghatti gum, tragacanth, karaya, carragheen, guar seed flour, carob seed flour, alginates, pectin, inulin or xanthan gum.
  • Preferred starch hydrolysates are multidextrins and dextrins.
  • Preferred carrier substances are silicon dioxide, gum Arabic and maltodextrins, wherein maltodextrins with DE values in the range 5 to 20 are in turn preferred. In this connection it is unimportant which plant originally provided the starch for the production of the starch hydrolysates. Maize (corn)-based starches as well as starches obtained from tapioca, rice, wheat or potatoes are suitable and readily available.
  • the carrier substances may at the same time also act as flow auxiliaries (anti-blocking agents), such as for example silicon dioxide.
  • compositions according to the invention which apart from the compound or compounds of the Formulae (I), (II), (III) or (IV) according to the invention also contain one or more solid carrier substances, can be produced for example by mechanical mixing processes, in which at the same time a comminution of the particles can also take place, or can be produced by means of spray drying.
  • compositions according to the invention which include solid carrier substances and are produced by means of spray drying; as regards spray drying reference is made to U.S. Pat. No. 3,159,585, U.S. Pat. No. 3,971,852, U.S. Pat. No. 4,532,145 or U.S. Pat. No. 5,124,162.
  • compositions according to the invention containing carrier substances and which have been produced by means of spray drying have a mean particle size in the range from 30 to 300 ⁇ m and a residual moisture of less than or equal to 5 wt. %.
  • the weight ratio of the total mass of the compounds of the Formulae (I) (I), (II), (III) or (IV) used according to the invention to the solid carrier substances suitable for nutritional purposes is preferably in the range from 1:10 to 1:100000, more preferably in the range from 1:100 to 1:20000, particularly preferably in the range from 1:1000 to 1:5000, referred to the dry mass of the composition.
  • the sum of the constituents of (i) compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention, and (ii) the carrier substance or substances in the composition is preferably in the range from 70 to 100 wt. %, more preferably in the range from 85 to 100 wt. %.
  • the invention also relates to a (preferably spray-dried) composition, which apart from one or more compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention as well as (ii) solid carrier substances, includes in addition (iii) one or more aroma compositions, or consists of the aforementioned components.
  • Such an aroma composition within the context of the present invention includes at least one volatile aroma substance (however, this term is understood as not including compounds of the Formula (I)).
  • the volatile aroma substance is in this connection preferably a sensorially active component with a vapour pressure of greater than or equal to 0.01 Pa at 25° C., preferably with a vapour pressure of greater than or equal to 0.025 Pa at 25° C.
  • the majority of volatile aroma substances have a vapour pressure of greater than or equal to 1 Pa at 25° C., and these aroma substances are therefore regarded as preferred for use in compositions according to the invention.
  • aroma substances which can be a constituent of the aroma composition can be found for example in K. Bauer, D. Garbe and H. Surburg, Common Fragrance and Flavor Materials, 4th. Ed., Wiley-VCH, Weinheim 2001.
  • organic acids saturated and unsaturated
  • alcohols saturated and unsaturated
  • sulfides and disulfides such as for example dimethyl sulfide, difurfuryl disulfide, methylthiopropanal
  • thiols such as for example methylfuranthiol
  • pyrazines and pyrrolines such as for example methylpyrazine, acetylpyrazine, 2-propionylpyrroline, 2-acetyl
  • the aroma compositions can also be used in the form of reaction aromas (Maillard products) and/or extracts and/or essential oils of plants or plant parts and/or fractions thereof.
  • a further preferred composition according to the invention suitable for consumption which includes one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, is a water-in-oil (W/O) emulsion.
  • W/O water-in-oil
  • such an emulsion includes water, an oily phase, one or more W/O emulsifiers, optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
  • composition (W/O emulsion) according to the invention contains
  • Such a W/O emulsion according to the invention particularly preferably consists of the aforementioned constituents in the aforementioned amounts.
  • the oily phase of such a W/O emulsion according to the invention contains (or consists of) preferably a fatty oil and/or an aroma composition.
  • Edible oils in particular vegetable oils, are for example suitable as fatty oils.
  • Suitable fatty oils are for example borage oil, thistle oil, groundnut oil, hazelnut oil, coconut oil, pumpkin seed oil, linseed oil, maize germ oil, macadamia nut oil, almond oil, olive oil, palm kernel oil, pecan nut oil, pistachio nut oil, rapeseed oil, rice seed oil, sesame oil, soya oil (soy bean oil), sunflower oil, walnut oil or wheat germ oil, or fractions obtainable therefrom.
  • Liquid neutral esters based on medium chain length fatty acids and glycerol can also be used, such as for example miglyols (for example miglyol 810, miglyol 812). Sunflower oil, palm kernel oil and rapeseed oil are preferred. Furthermore, fractionated coconut oils which principally contain fatty acid residues with 6 to 8 C atoms are preferably used. These are characterized by their taste neutrality as well as by their good oxidation stability.
  • the edible W/O emulsifier is selected from the group consisting of lecithin (E 322), monoglycerides and diglycerides of edible fatty acids (E 471), acetic acid monoglycerides (E 472a), lactic acid monoglycerides (E 472b), citric acid monoglycerides (E 472c), tartaric acid monoglycerides (E 472d), diacetyltartaric acid monoglycerides (E 472e), and sorbitan monostearate (E 491).
  • lecithin E 322
  • monoglycerides and diglycerides of edible fatty acids E 471
  • acetic acid monoglycerides E 472a
  • lactic acid monoglycerides E 472b
  • citric acid monoglycerides E 472c
  • tartaric acid monoglycerides E 472d
  • diacetyltartaric acid monoglycerides E 472e
  • Suitable antioxidants and substances which can intensify the antioxidative action are the naturally occurring tocopherols and their derivatives, tocotrienols, flavonoids, ascorbic acids and its salts, alpha-hydroxy acids (for example citric acid, lactic acid, malic acid, tartaric acid) and their Na, K and Ca salts, constituents isolated from plants, or extracts or fractions thereof, for example from tea, green tea, algae, grape seeds, wheat germs, rosemary, oregano, flavonoids, quercetin, phenolic benzylamines.
  • tocopherols and their derivatives for example citric acid, lactic acid, malic acid, tartaric acid
  • alpha-hydroxy acids for example citric acid, lactic acid, malic acid, tartaric acid
  • Na, K and Ca salts constituents isolated from plants, or extracts or fractions thereof, for example from tea, green tea, algae, grape seeds, wheat germs, rosemary, oregano, flavonoids, quercetin, phenolic
  • antioxidants are propyl gallate, octyl gallate, dodecyl gallate, butylhydroxyanisole (BHA), butylhy-droxytoluene (BHT), lecithins, monoglycerides and diglycerides of edible fatty acids esterified with citric acid, orthophosphates, and Na, K and Ca salts of monophosphoric acid and ascorbyl palmitate.
  • BHA butylhydroxyanisole
  • BHT butylhy-droxytoluene
  • lecithins monoglycerides and diglycerides of edible fatty acids esterified with citric acid, orthophosphates, and Na, K and Ca salts of monophosphoric acid and ascorbyl palmitate.
  • the W/O emulsions according to the invention are particularly suitable for application to foodstuffs surfaces, the foodstuffs preferably having a water content of at most 10 wt. %, preferably of at most 5 wt. %.
  • the W/O emulsion according to the invention has at the application temperature a sufficiently low viscosity so that it is possible to apply the W/O emulsion by means of spraying.
  • Preferred foodstuffs on the surface of which a W/O emulsion according to the invention can be applied are for example crackers, chips/crisps (for example based on potatoes, maize, grain or bread), extruded nibbles/snack articles (e.g.
  • W/O emulsions according to the invention are normally applied to the foodstuffs surfaces in an amount of 0.5 to 6 wt. %, referred to the total weight of the foodstuff.
  • one aspect of the present invention relates to the use of a compound of the above Formulae (I), (II), (III) or (IV) (in particular a compound specified above as preferred) for the production, modification or intensification of an umami taste.
  • the compounds of the Formulae (I), (II), (III) or (IV) used according to the invention in a flavor-active amount) or the compositions according to the invention are employed in (i) ready-to-serve or ready-to-eat preparations or (ii) semi-finished products serving for nutritional or consumption purposes, in particular in preparations with reduced sodium glutamate content or free from sodium glutamate serving for nutritional or consumption purposes.
  • reduced sodium glutamate content means that the preparation or semi-finished product according to the invention contains significantly less sodium glutamate than is contained in the conventional preparation or semi-finished product; the sodium glutamate content is in this connection 5 to ⁇ 100 wt. %, preferably 10 to 50 wt. %, particularly preferably 20 to 50 wt. % below the sodium glutamate content of the conventional preparation.
  • a preparation of semi-finished product according to the invention contains, apart from one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, also sodium glutamate, then the weight ratio of the total amount of compounds of the Formulae (I), (II), (III) or (IV) to sodium glutamate is preferably in the range from 1:1 to 1:200.
  • ready-to-serve or ready-to-eat preparations serving for nutritional or consumption purposes contain one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, preferably in an amount in the range from 0.01 ppm to 100 ppm, more preferably in the range from 0.1 ppm to 50 ppm, particularly preferably in the range from 0.1 ppm to 30 ppm, most preferably in the range from 1 ppm to 30 ppm, referred to the total weight of the ready-to-serve or ready-to-eat preparation.
  • Semi-finished products according to the invention serving for nutritional or consumption purposes contain one or more compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention, preferably in an amount in the range from 10 ppm to 800 ppm, more preferably in the range from 25 ppm to 750 ppm, particularly preferably in the range from 50 ppm to 700 ppm, referred to the total weight of the semi-finished product.
  • sodium glutamate-reduced preparations according to the invention which contain sodium glutamate, wherein the amount of sodium glutamate is not sufficient to be detected as a satisfactory umami taste in a comparison preparation that does not contain a mixture according to the invention but is of otherwise identical composition (normal sodium glutamate-reduced preparation), and the amount of the mixture according to the invention is sufficient to achieve a satisfactory umami taste impression.
  • Preparations in the context of the invention serving for nutritional or consumption purposes are in particular bakery items (e.g. bread, crackers/biscuits, cakes, other baked items), beverages (e.g. vegetable juices, vegetable juice preparations), instant drinks (e.g. instant vegetable drinks), meat products (e.g. ham, fresh sausage or raw sausage preparations), spicy or marinated fresh or pickled fish products (e.g. surimi), eggs or egg products (dried eggs, egg white, egg yellow), cereal products (e.g. pre-cooked ready-to-serve rice products, rice flour products, millet and sorghum products, raw or pre-cooked noodles and pasta products), dairy produce (e.g.
  • bakery items e.g. bread, crackers/biscuits, cakes, other baked items
  • beverages e.g. vegetable juices, vegetable juice preparations
  • instant drinks e.g. instant vegetable drinks
  • meat products e.g. ham, fresh sausage or raw sausage preparations
  • spicy or marinated fresh or pickled fish products e.g
  • soya protein or other soya bean fractions e.g. soya milk and products prepared therefrom
  • soya lecithin-containing preparations fermented products such as tofu or tempe, or products prepared therefrom, soya sauces
  • vegetable preparations e.g ketchups, sauces, dried vegetables, deepfrozen vegetables, pre-cooked vegetables, vegetables pickled in vinegar, vegetable concentrates or pastes, boiled vegetables, potato preparations
  • nibble/snack articles e.g.
  • baked or fried potato crisps or potato dough products bread dough products, extrudates based on maize, rice or groundnuts
  • products based on fats and oils or emulsions thereof e.g. mayonnaise, remoulade, spreads, dressings, spice preparations
  • other ready-to-serve dishes and soups e.g. dried soups, instant soups, pre-cooked soups
  • sauces instant sauces, dried sauces, ready-to-serve sauces
  • spices seasonings or spice/seasoning preparations (e.g. mustard preparations, horseradish preparations, marinades), spice mixtures as well as, in particular, seasonings, which are used for example in the snack sector.
  • sodium glutamate-reduced sodium glutamate-containing semi-finished products or preparations serving for nutritional or consumption purposes e.g. bakery items (bread, crackers/biscuits, cakes, other bakery items), vegetable juice preparations, meat products (e.g. ham, fresh sausage or raw sausage preparations, spicy or marinated fresh or pickled meat products), eggs or egg products (dried eggs, egg white, egg yellow), cereal products (e.g. pre-cooked ready-to-serve rice products, raw or pre-cooked noodles and pasta products), dairy produce (e.g.
  • soya protein or other soya bean fractions e.g. soya milk and products prepared therefrom
  • soya lecithin-containing preparations fermented products such as tofu or tempe or products prepared therefrom, soya sauces
  • fish sauces such as for example anchovy sauces, oyster sauces
  • vegetable preparations e.g ketchups, sauces, dried vegetables, deepfrozen vegetables, pre-cooked vegetables, vegetables pickled in vinegar, boiled vegetables, potato preparations
  • nibbles/snack articles e.g.
  • baked or fried potato crisps or potato paste products bread dough products, extracts based on maize or groundnuts
  • products based on fats and oils or emulsions thereof e.g. mayonnaise, remoulades, dressings, spice preparations
  • ready-to-serve dishes soups (e.g. dried soups, instant soups, pre-cooked soups), soup or bouillon cubes, sauces (instant sauces, dried sauces, ready-to-serve sauces), spices, relishes, condiments, spice mixtures as well as, in particular, seasonings, which are used for example in the snack sector.
  • the preparations in the context of the invention can also be in the form of capsules, tablets (non-coated as well as coated tablets, e.g. coatings resistant to gastric juices), pills, granules, pellets, solid mixtures, dispersions in liquid phases, as emulsions, as powders, as solutions, as pastes or as other preparations that can be swallowed or chewed, for example as dietary and nutritional supplements.
  • the semi-finished products according to the invention serve as a rule for the production of ready-to-serve or ready-to-eat preparations serving for nutritional or consumption purposes.
  • semi-finished products according to the invention and serving for nutritional or consumption purposes can be used to intensify the umami taste of nutritional and food products with reduced sodium glutamate content, and can also be used directly as spices for the industrial or non-industrial preparation of nutritional and/or food products.
  • Semi-finished products according to the invention preferably contain a total amount of 10 ppm to 800 ppm, more preferably 25 ppm to 750 ppm and in particular 50 ppm to 700 ppm of compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention,
  • the preparations or semi-finished products according to the invention are preferably produced by dissolving and mixing the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention in mixtures of ethanol and optionally demineralized and/or purified water, following which the solutions are converted by a drying process, preferably a spray drying, vacuum freeze drying, reverse osmosis, vaporisation or other concentration process or a combination of the aforementioned processes, into an (at least almost) solid preparation.
  • a drying process preferably a spray drying, vacuum freeze drying, reverse osmosis, vaporisation or other concentration process or a combination of the aforementioned processes, into an (at least almost) solid preparation.
  • the drying can take place with the assistance of carrier substances (for example starch, starch derivatives, maltodextrin, silica gel, see above) or auxiliary substances (for example natural gums, stabilising agents).
  • carrier substances for example starch, starch derivatives, maltodextrin,
  • Preferred preparations or semi-finished products according to the invention are spices, spice mixtures, condiments, soup cubes, instant soups, instant sauces, vegetarian ready-cooked dishes, meat-containing ready-cooked dishes, fish sauces such as for example anchovy sauces, oyster sauces, and soya sauces.
  • compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention as well as optionally other constituents are first of all incorporated into emulsions, into liposomes (for example obtained from phosphatidyl choline), into microspheres, into nanospheres or also into capsules, granules or extrudates of a matrix suitable for foodstuffs and luxury foods (for example from starch, starch derivatives, cellulose or cellulose derivatives such as hydroxypropylcellulose, other polysaccharides such as alginate, natural fats, natural waxes such as beeswax or carnauba wax, or from proteins such as gelatins).
  • the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are complexed with one or more suitable complex-forming agents, for example with cyclodextrins or cyclodextrin-derivatives, preferably alpha-cyclodextrin or beta-cyclodextrin, and are employed in this complexed form.
  • suitable complex-forming agents for example with cyclodextrins or cyclodextrin-derivatives, preferably alpha-cyclodextrin or beta-cyclodextrin
  • preparations according to the invention in which the matrix is chosen so that the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are released in a delayed manner from the matrix, so that a long-lasting action is obtained.
  • natural fats for example beeswax, carnauba wax
  • natural bulking substances wheat fibres, apple fibres, oat fibres, orange fibres
  • Further constituents (ingredients) of a ready-to-eat preparation or semi-finished product according to the invention serving for nutritional or consumption purposes can be conventional base substances, auxiliary substances and additives for nutritional or consumption purposes, for example water, mixtures of fresh or processed, vegetable or animal base substances or raw materials (for example raw, roasted, dried, fermented, smoked and/or cooked meat, bones, cartilage, fish, vegetables, herbs, nuts, vegetable juices or pastes or mixtures thereof), digestible or indigestible carbohydrates (e.g. sucrose, maltose, fructose, glucose, dextrins, amylose, amylopectin, inulin, xylans, cellulose, tagatose), sugar alcohols (e.g.
  • sorbitol erythritol
  • natural or hardened fats e.g. suet, lard, palm oil, coconut butter, hardened vegetable oil
  • oils for example sunflower oil, groundnut oil, maize seed oil, olive oil, fish oil, soya oil, sesame oil
  • fatty acids or their salts e.g.
  • potassium stearate proteinaceous or non-proteinaceous amino acids and related compounds (for example ⁇ -aminobutyric acid, taurine), peptides (for example glutathione), natural or processed proteins (for example gelatins), enzymes (for example peptidases), nucleic acids, nucleotides, taste corrigents for unpleasant taste impressions, further taste modulators for further, generally unpleasant taste impressions, other taste-modulating substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phen-oxypropionic acid), emulsifiiers (for example lecithins, diacyl glycerols, gum arabic), stabilizers (for example carrageen, alginate), preservatives (for example benzoic acid and its salts, sorbic acid and its salts), antioxidants (for example tocopherol, ascorbic acid), chelating
  • compositions, preparations or semi-finished products according to the invention contain an aroma composition in order to round off and refine the taste and/or the smell.
  • a composition according to the invention which contains as further constituents a solid carrier substance and an aroma composition, has already been described in more detail above.
  • Suitable aroma compositions contain for example synthetic, natural or natural-identical aroma substances, fragrances and flavor substances, reaction aromas, smoke aromas or other aroma-imparting preparations (for example protein (partial) hydrolysates, grill aromas, plant extracts, spices, spice preparations, vegetables and/or vegetable preparations) as well as suitable auxiliary substances and carrier substances.
  • suitable in this case are the aroma compositions not according to the invention or their constituents which produce a roasted, fish/meat-like (in particular chicken, fish, seafood, beef, pork, lamb, mutton, goat), vegetable-like (in particular tomato, onion, garlic, celery, leek, mushroom, aubergine, seaweed), spicy (in particular black and white pepper, chilli, paprika, cardamom, nutmeg, allspice, mustard and mustard products), roasted, yeast-like, boiled, fatty/oily, salty and/or sharp aroma impression and can thus intensify the spicy impression.
  • the aroma compositions contain more than one of the aforementioned ingredients.
  • the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are employed in the compositions, preparations and semi-finished products according to the invention in combination with at least one (further, not per se according to the invention) substance in order to mask or reduce an unpleasant (bitter, metallic, chalky, acidic, astringent) taste impression or to intensify or produce a pleasant taste impression (sweet, salty, umami). In this way an intensification of the taste, in particular the umami taste, can be achieved.
  • nucleotides for example adenosine-5′-monophosphate, cytidine-5′-monophosphate, inosine-5′-monophosphate, guanosine-5′-monophosphate
  • pharmaceutically acceptable salts lactisols
  • hydroxyflavanones for example eriodictyol, homoeriodictyol or their sodium salts
  • hydroxybenzoic acid amides for example 2,4-dihydroxybenzoic acid vanillylamide, 4-hydroxybenzoic acid vanillylamide
  • mixtures of whey proteins with lecithins yeast extracts, plant hydrolysates, powdered vegetables (for example onion powder, tomato powder), plant extracts (for example from lovage or from mushrooms such as shiitake), seaweed and mineral salt mixtures.
  • Modulating aroma substances and/or flavor substances are preferably selected from the group consisting of adenosine-5′-monophosphate, cytidine-5′-monophosphate, inosine-5′-monophosphate, and their pharmaceutically acceptable salts; lactisols; 2,4-dihydroxybenzoic acid; 3-hydroxybenzoic acid; sodium salts, preferably sodium chloride, sodium lactate, sodium citrate, sodium acetate, sodium gluconate; hydroxyflavonones, such as for example eriodictyol, homoeriodictyol and their sodium salts; hydroxybenzoic acid amides, such as for example 2,4-dihydroxybenzoic acid vanillylamide, 2,4-dihydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide, 2,4,6-trihydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide, 2-hydroxy-benzoic acid-N-4-(hydroxy
  • a further aspect of the present invention is also a process for generating, modifying or intensifying a flavor, in particular an umami flavor, in (i) a ready-for-use or ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes.
  • a process according to the invention includes the following step:
  • a further aspect of the present invention relates to new compounds of the Formulae (I), (II), (III) and (IV).
  • the compounds already known from the document US 2004/0209859 A1 in particular the individual compounds listed hereinbefore, insofar as they fall under Formula (I), are not the subject-matter of the present invention, although their use is (see in this connection the accompanying patent claims).
  • the compounds mentioned in the description, in particular in paragraphs [0059] to [0120] and the compounds mentioned in the examples of US 2004/0209859 A1, in particular in Examples 38 and 49, are not the subject-matter of the present invention.
  • a further aspect of the present invention relates to a process for the production of a compound of the Formulae (IVa), (IVc), (E), (B), (P) or (H) comprising the following steps:
  • R1 denotes alkyl
  • a compound capable of forming a carbine, with which a compound of the Formula (V) is reacted is preferably an alkyl diazoacetate. Particularly preferred in this connection is ethyl diazoacetate (diazoacetic acid ester).
  • a compound of the Formula (V) reacts with ethyl diazoacetate to form a compound of the Formula (VI), in which Rc denotes ethyl.
  • Preferred compounds suitable for the preparation of acid chlorides are oxalyl chloride or thionyl chloride.
  • R1 denotes methyl
  • R7 denotes isopropyl
  • Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • the test panel evaluated the strength of the specified flavors in each case by awarding points on a scale from 0 (no corresponding taste) to 6 (very pronounced corresponding taste). The mean values of the respective scores are shown.
  • FIG. 1 Taste comparison of (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide with sodium glutamate.
  • the taste of a 0.5% American beef extract as base was compared on the basis of an evaluation by a panel of trained testers with the taste firstly of such a base to which 5 ppm of (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide had been added (continuous, dark line), and secondly of such a base to which 0.05 wt. % of MSG had been added (dotted line).
  • FIG. 2 Taste comparison of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) with sodium glutamate.
  • B1 taste comparison of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) with sodium glutamate.
  • the taste of a 0.5% American beef extract as base was compared on the basis of an evaluation by a panel of trained testers to the taste firstly of such a base to which 2 ppm of a mixture of 1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) had been added (continuous, dark line), and secondly of such a base to which 0.05 wt. % of MSG had been added (dotted line).
  • FIG. 3 Taste comparison of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid-cyclopentylamide (P2) with sodium glutamate.
  • the crude acid chloride is dissolved in dichloromethane. 5.7 ml of ethylamine solution (70% in water) are added dropwise while stirring. The reaction mixture is stirred for 16 hours at room temperature, washed twice with 10 ml of water, dried over sodium sulfate and the solvent is distilled off under vacuum.
  • fraction B is purified further by preparative HPLC.
  • Step a Cyclopropanecarboxylic Acid Ethyl Ester by Addition of Ethyl Diazoacetate to Alkenes
  • Step b Cyclopropanecarboxylic Acid by Saponification of the Cyclopropanecarboxylic Acid Ethyl Ester
  • Step c Preparation of the Acid Chloride and Subsequent Aminolysis to the Alkylamide
  • the aforementioned substance was prepared according to the general synthesis procedure, cyclohexene being used as alkene.
  • the aforementioned substance was prepared according to the general synthesis procedure, 1-isopropylcyclohex-2-ene being used as alkene.
  • the aforementioned substance was prepared according to the general synthesis procedure, 1,3-dimethylcyclohex-4-ene being used as alkene.
  • the constituents are dissolved in a mixture of ethanol and demineralized water and then spray-dried.
  • Part A was weighed out. 290 ml of water were placed in a vessel and Part A was added and dissolved while stirring. The solution is diluted with water to 1.84 kg (pH 6.0) and then freeze-dried (eutectic point: ⁇ 15° C.; operating vacuum: 0.52 mbar; shelf temperature: ⁇ 5° C. to +25° C.). The product is mixed with ground mustard seeds and the mustard aroma from Part B and formulated into a spice.
  • the comparison preparation A and the preparation C according to the invention were awarded the same scores.
  • the preparation B according to the invention the umami taste (and mouthfeel) were described as recognizable, but less strong compared to the preparations A and C.
  • the preparation D according to the invention was judged to have a very pronounced umami taste (and mouthfeel) and was awarded a much higher score than the preparations A and C.
  • the comparison preparation A and the preparation C according to the invention were awarded the same scores.
  • the preparation B according to the invention the umami taste (and mouthfeel) were described as recognizable, but less strong compared to the preparations A and C.
  • the preparation D according to the invention was judged to have a very pronounced umami taste (and mouthfeel) and was awarded a much higher score than the preparations A and C.
  • each of the preparations A, B, C and D were in each case uniformly sprinkled over 100 g of pork neck cutlets and pan-fried.
  • the comparison preparation A and the preparation C according to the invention were awarded the same score.
  • the preparation B according to the invention the umami taste (mouthfeel) was described as recognizable, but not as pronounced as in the case of the preparations A and C.
  • the preparation D according to the invention was judged to have a very pronounced umami taste (mouthfeel) and was awarded a much higher score than the preparations A and C.
  • Preparation B Comparison according to according to Constituent Preparation A the invention the invention Sodium glutamate 6 g — Cooking salt 2 g 2 g 2 g Starch, Farinex WM 55 1 g 1 g 1 g Sucrose 12 g 12 g 12 g Tomato concentrate ⁇ 2 36 g 36 g 36 g Glucose syrup 80 Brix 18 g 18 g 18 g Brandy vinegar 10% 7 g 7 g 7 g 7 g Water 18 g 23.8 g 23.5 g Compound of the Formula — 0.2 g 0.5 g (P1) & (P2) in the ratio 3:2
  • the ingredients are mixed in the specified order and the ready ketchup is homogenized by means of a stirrer, filled in bottles and sterilized.
  • Preparation B according to the invention according to the invention Sodium 3.50 g 2 g 2 g — glutamate Cheese powder 10.00 g 10.00 g 10.00 g 10.00 g Garlic powder 2.00 g 2.00 g 2.00 g Whey powder 38.86 g 38.86 g 38.86 g 38.86 g Spice extract oil 0.20 g 0.20 g 0.20 g 0.20 g Paprika powder 9.80 g 9.80 g 9.80 g 9.80 g 9.80 g 9.80 g Cooking salt 21.00 g 21.00 g 21.00 g 21.00 g Tomato powder 9.00 g 9.00 g 9.00 g 9.00 g Dry aroma 2.50 g 2.50 g 2.50 g 2.50 g Silicon dioxide 0.02 g 0.02 g 0.02 g 0.02 g Vegetable oil 0.02 g 0.02 g 0.02 g 0.02 g 0.02 g.
  • Preparation B according to the invention according to the invention Starch 40.00 g 40.00 g 40.00 g 40.00 g Maltodextrin 33.10 g 33.10 g 33.10 g Cooking salt 6.00 g 6.00 g 6.00 g 6.00 g Spray-dried sugar 5.00 g 5.00 g 5.00 g coloring Yeast extract 3.00 g 3.00 g 3.00 g powder Sodium glutamate 2.00 g 1.30 g 1.30 g — Sugar 0.50 g 0.50 g 0.50 g 0.50 g 0.50 g Powdered fat 5.00 g 5.00 g 5.00 g 5.00 g Tomato powder 3.00 g 3.00 g 3.00 g 3.00 g Natural vegetable 1.00 g 1.00 g 1.00 g 1.00 g extract Onion extract 0.30
  • Preparation B Water 50.65 g 50.65 g 50.65 g 50.65 g Vegetable oil 5.50 g 5.50 g 5.50 g Tomato paste 24.00 g 24.00 g 24.00 g 24.00 g Cream 1.05 g 1.05 g 1.05 g 1.05 g Sugar 2.00 g 2.00 g 2.00 g Cooking salt 1.70 g 1.70 g 1.70 g Sodium 0.40 g 0.25 g 0.25 g — glutamate Wheat flour 5.50 g 5.50 g 5.50 g 5.50 g Starch 1.20 g 1.20 g 1.20 g 1.20 g Chopped 8.00 g 8.00 g 8.00 g 8.00 g tomatoes Spray-dried — — 0.20 g 0.40 g composition according to
  • the solid ingredients were weighed out, mixed, and added to the water.
  • the vegetable oil was poured in and the tomato paste was added.
  • the mixture was boiled while stirring.
  • the evaluation of the umami taste was carried out in a similar way to Application Example 1.
  • Parts A to D were mixed and intensively kneaded.
  • the raw composition can be processed for example in the form of thin strips into ready-to-use chewing gum.
  • R a and R b denote independently of one another hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methyl-butyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethyl-propyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methyl-pentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethyl-butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-di
  • Specific embodiment nine comprises use according to one of specific embodiment six to eight, wherein:

Abstract

The present invention relates to the use of a compound of the Formula (I)
Figure US20100189863A1-20100729-C00001
    • wherein:
    • R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
    • with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least one further of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
    • Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl;
    • and
    • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms as a food flavor substance.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims benefit of priority to PCT/EP2007/061171, filed on Oct. 18, 2007, which asserts priority to U.S. Provisional Application No. 60/829,958, filed on Oct. 18, 2006, which are incorporated herein by reference in their entireties.
  • The present invention relates to the use of specific substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides and specific derivatives thereof of the Formula (I) (see below) as food flavor substances (taste substances). The compounds are suitable in particular for producing, modifying or intensifying an umami flavor. The invention relates furthermore to specific compositions and semi-finished products which contain a flavor-imparting effective amount of the aforementioned compounds of the Formula (I), as well as specific methods for producing, modifying and/or intensifying specific flavor impressions, in particular the umami taste. Finally, the invention also relates to new compounds of the Formula (I) (see below) that impart special flavor impressions.
  • Aroma substances and compounds with unusual sensorial properties, which carry an amide group, have been known for some time. Thus, for example, many important cooling substances such as WS3, WS5 and WS23 have an amide structure:
  • Figure US20100189863A1-20100729-C00002
  • Sensorially important amides also include the hot-tasting substances capsaicin from Chili pods and the piperin of white pepper. The naturally occurring alkamides pellitorin and spilanthol have, apart from a saliva-generating and tingling action, also a long-lasting and numbing effect in the mouth:
  • Figure US20100189863A1-20100729-C00003
  • Based on the chemical structure of spilanthol, various alkylidene amides have been proposed in US 2004/0202760 and US 2004/0202619, which include quite different sensorial impressions such as tingling, numbing, acerbity, sensation of fullness in the mouth (mouthfeel), etc. For some compounds such as N-cyclopropyl-E2,Z6-nonadiene amide, N-ethyl-E2,Z6-dodecadiene amide and N-ethyl-E2,Z6-nonadiene amide an MSG-like action (MSG=monosodium glutamate, sodium glutamate) and/or an umami-like impression are also mentioned.
  • In the documents US 2006/0068071/EP 1642886/US 2006/0057268 saturated, unsaturated and cyclopropyl-N-alkylamides are disclosed, which are said to have taste-promoting or aroma-promoting actions.
  • A large number of allegedly flavor-active non-natural amides are described in the publication US 2005/084506 A1.
  • Several publications, listed in the following table, are concerned with the synthesis of bicyclo[4.1.0]heptane-7-carboxylic acid amides of the structure shown below.
  • Figure US20100189863A1-20100729-C00004
    Radical
    R1 Literature
    H2N— Hans Musso, Chem. Berichte (1968), 101(11), 3710-3720.
    H2N— Donald B. Denny et al., J. Am. Chem Soc. (1962),
    84, 3944-3946.
    Me2N— Michael P. Doyle et al., Tetrahedron Letters 1987,
    28(8), 833-836.
    Et2N— Toshikazu Hirao et al., Tetrahedron Letters (1985),
    26(41), 5061-5064.
    H2N—NH— I. A. Dýakonov et al., Zhurnal Obshchei
    Khimii (1967), 3(8), 141-148.
    H2N—NH— I. G. Bolesov et. al., Zhurnal Organicheskoi Khimii
    (1974), 10(10), 2107-2113.
    PhHN— P. Besinet et al., Bulletin de la Societe Chimique
    de France (1969), 1377-1381.
    PhHN— Max Mousseron, Compt. rend. (1956),
    243, 1880-1882.
  • In this connection Me denotes methyl, Et denotes ethyl and Ph denotes phenyl.
  • Alkylamides where R1=NH-alkyl are not disclosed in the above publications.
  • Several documents describe bicyclo[4.1.0]heptane-7-carboxylic acid amides as having biological or pharmacological actions. These are in particular the following documents:
  • WO 2004/032716: Modulation of cholesterol transport by regulating the HDL Scavenger Receptor SR-BI.
  • The following compound with a bicyclo[4.1.0]heptane-7-carboxylic acid amide structure is specified:
  • Figure US20100189863A1-20100729-C00005
  • U.S. Pat. No. 5,123,951: Plant growth regulators.
  • The following compound with a bicyclo[4.1.0]heptane-7-carboxylic acid amide structure is specified:
  • Figure US20100189863A1-20100729-C00006
  • WO 2005/007141: Inhibitors of the POSH ubiquitin ligase for the treatment of neurological and viral diseases and cancer.
  • The following compound with a bicyclo[4.1.0]heptane-7-carboxylic acid amide structure is specified:
  • Figure US20100189863A1-20100729-C00007
  • Two literature references describe bicyclo[4.1.0]heptane-7-carboxylic acid amides, which are substituted with two alkyl substituents on the bicyclic skeleton. In particular the following patent is one of the references:
  • US 2004/209859 discloses the use of di-substituted and tri-substituted bicyclo[4.1.0]heptane-7-carboxylic acid derivatives as anticonvulsive compounds used inter alia for the treatment of migraine, epilepsy or dipolar disorders.
  • In this connection the following general formula is given for the active class of compounds:
  • Figure US20100189863A1-20100729-C00008
  • wherein:
    A denotes cycloalkyl or bicycloalkyl
    Ra, Rb, Rc denote independently of one another H or alkyl
    R1 denotes OR2 or NR3R4
    where R2 denotes H or alkyl, and R3, R4 independently of one another denote for example H, alkyl or alkenyl.
  • Examples of amides covered by the general formula are listed as individual compounds:
  • Figure US20100189863A1-20100729-C00009
  • *: with each of the compounds identified by an asterisk *, it is not clear whether this is actually disclosed in the document US 2004/209859. In the heading to Example 38 of the publication 2,7,7-trimethyl-tricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (C) is for example mentioned; the product of the described synthesis is however (1S,6R)-2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (A). In the heading to Example 49, 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (D) is mentioned; the product of the described synthesis is however (1R,6R)-2,7,7-trimethyl-tricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (B).
  • Furthermore, the analogous derivatives in the form of the amides of glycinamide are listed as individual compounds:
  • Figure US20100189863A1-20100729-C00010
    Figure US20100189863A1-20100729-C00011
  • *: In the case of each of the compounds identified by an asterisk * it is not clear whether this is actually disclosed in the document US 2004/209859. In the heading to Example 39 of the publication N-(2-amino-2-oxoethyl)-2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (C′) for example is mentioned; the product of the described synthesis is however (1S,6R)—N-(2-amino-2-oxoethyl)-2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (A′). In the heading to Example 50N-(2-amino-2-oxoethyl)-4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (D′) is mentioned; the product of the described synthesis is however (1R,6S)—N-(2-amino-2-oxoethyl)-2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide (B′).
  • Jeganathan et al. describe in J. Org. Chem. 1986, 51, 5362-5367 the addition of N-(4-azidophenyl)-1-diazoacetamides to dialkyl-substituted cyclohexenes. The bicyclo[4.1.0]heptane-7-carboxylic acid amides formed thereby have, as N-aryl amides, the following structure:
  • Figure US20100189863A1-20100729-C00012
  • The flavor of bicyclo[4.1.0]heptane-7-carboxylic acid amides (and their derivatives, i.e. substituted or unsubstituted) has not up to now been mentioned in any literature reference.
  • There is furthermore a need to discover new food flavor substances and aroma substances, flavor-active compounds, or compounds which can produce, modify or intensify an aroma. In particular there is a need for those compounds which can produce or intensify the “umami” flavor impression.
  • In the search for such compounds it was surprisingly found that specific substituted bicyclo[4.1.0]heptane-7-carboxylic acid alkylamides of the Formula (I) (see below) are strong food flavor substances.
  • A first aspect of the present invention therefore relates to the use of a compound of the Formula (I)
  • Figure US20100189863A1-20100729-C00013
  • wherein:
    R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
    with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least a further one of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
    Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl, preferably hydrogen or methyl, particularly preferably both denote hydrogen;
    and
    Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms
    as a food flavor (taste) substance.
  • Preferably in this connection three, four, five or six of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 denote hydrogen.
  • The total number of carbon atoms of a compound of the Formula (I) used according to the invention is preferably not greater than 25, preferably not greater than 20.
  • According to a modification of the use according to the invention it is preferred if the compound of the Formula (I) comprises in each case hydrogen as radicals R2, R4, R6 and R8 and is thus a compound of the Formula (II)
  • Figure US20100189863A1-20100729-C00014
  • wherein;
    R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms,
    with the proviso that at least 1 of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen,
    wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms,
    Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl,
    and
    Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
  • With regard to the preferred compounds of the Formula (II) used according to the invention, the comments made above with regard to the compounds of the Formula (I) apply.
  • It is preferred to use a compound of the Formula (I) (preferably of the Formula (II)), in particular one of the preferred compounds described above and hereinafter, for producing, modifying or intensifying an umami taste.
  • The cyclopropanecarboxylic acid ethylamide not according to the invention and illustrated hereinafter has, as our own investigations have shown, a very weak umami taste at concentrations of 10 ppm in aqueous solutions.
  • Figure US20100189863A1-20100729-C00015
  • However, in sensorial tests the compound does not make any statistically significant contribution to the mouthfeel, as our own tests with meat broth/consommé compositions have established.
  • The unsubstituted bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide not according to the invention has no detectable taste (the following drawing shows the numbering of the positions on the basic skeleton):
  • Figure US20100189863A1-20100729-C00016
  • By simply adding a single alkyl substituent the resulting compound, not according to the invention, has a slight sensorial activity, as our own investigations have shown. Thus, for example, 2-isopropyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide has a slight salt-intensifying effect and a very slight, umami-like intrinsic taste:
  • Figure US20100189863A1-20100729-C00017
  • It has now surprisingly been found however that the sensorial effects are significantly increased by a second alkyl substituent. The 2,4-dimethyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide according to the invention also has, like the just discussed mono alkyl-substituted compound, a slight salt-intensifying effect, but on the other hand has a stronger, umami-like intrinsic taste:
  • Figure US20100189863A1-20100729-C00018
  • An important factor for the sensorial effectiveness of a compound of the Formula (I) is generally the position of the substituents. In our own investigations di-substituted compounds of the Formula (I) with substituents on the 2 and 4 positions or on the 2 and 5 positions have proved particularly advantageous.
  • A use according to the invention of a compound of the Formula (I) is therefore preferred, in which the compound of the Formula (I) is
      • a compound of the Formula (III),
  • Figure US20100189863A1-20100729-C00019
  • wherein:
    R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
    or
      • is a compound of the Formula (IV)
  • Figure US20100189863A1-20100729-C00020
  • wherein:
    R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
    wherein in Formula (III) and Formula (IV):
    Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
  • Preferably in this connection R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV) denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl or 1,2,2-trimethylpropyl,
  • or jointly denote a —CH2—, —C(Me)2-, —CH2CH2- or —CH═CH—-bridge.
  • With a compound according to the invention compounds of the Formula (III) or (IV) are preferred, in which Ra and Rb independently of one another denote hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl
  • or denote an alkenyl radical with 2 to 6 C atoms,
    or denote a cycloalkyl radical with 3 to 6 C atoms,
    wherein preferably Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • Particularly preferred is the use according to the invention of compounds of the Formula (III) or (IV) in which
  • Ra denotes hydrogen
    and
    Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl,
    or denotes an alkenyl radical with 2 to 6 C atoms or denotes a cycloalkyl radical with 3 to 6 C atoms, preferably ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl
    or
    Ra and Rb both denote methyl.
  • Tricyclo[3.2.1.02,4]octane-3-carboxylic acid ethylamide has a distinct umami taste and a salt-intensifying effect. In sensorial tests a statistically significant increase in the mouthfeel is found already at concentrations of 50 ppm in broths/consommés made from American beef extract:
  • Figure US20100189863A1-20100729-C00021
  • In sensorial tests it has been found that the relative configuration of the stereocenters has a large influence on the taste properties of compounds of the Formula (I). From the taste aspect the use according to the invention of a compound of the Formula (I) which is one of the two enantiomeric compounds of the Formula (IVa),
  • Figure US20100189863A1-20100729-C00022
  • is in particular preferred.
  • As regards the preferred meanings of the substituents R1, R7 and Rb the comments made above apply as appropriate.
  • 2-Isopropyl-5-methyl-2-ispropyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide has particularly strong sensorial properties. In this connection the relative configuration of the stereogenic centers is of great importance. The compound with the absolute stereo-chemistry (as shown in the following structural formula) (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide has a slight cooling effect in sensorial tests, but tastes only moderately of umami:
  • Figure US20100189863A1-20100729-C00023
  • In contrast to this the diastereomeric compound (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (Formula (IVc)) has no cooling effect, but has a very strongly pronounced intrinsic umami taste:
  • Figure US20100189863A1-20100729-C00024
  • This compound of the Formula (IVc) also intensifies the saltiness, the sweetness and the umami taste of aroma compositions. In our own investigations a trained panel found, again in a statistically significant manner, that simply by adding 5 ppm of the compound to 0.5 wt. % of American beef bouillon, the mouthfeel is increased by roughly the same extent as is normally achieved only by the addition of 0.05 wt. % of MSG.
  • A mixture of both diastereomers specified above, which can be obtained for example as the product of a synthesis starting from (+)-p-menth-(2)-ene, is completely dominated by the umami impression of the (1R,2S,5R,6S,7R) isomer, and by comparison the cooling impression can no longer be detected.
  • For this reason a diastereomeric mixture was employed in each case for the further sensorial evaluations.
  • In further investigations it was found that also a mixture of the two diastereomers (1R,2R,5S,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (E1) and (1S,2R,5S,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (E2), which are enantiomeric to (IVb) and (IVc), have an intrinsic umami taste.
  • Figure US20100189863A1-20100729-C00025
  • By varying the amine used it was surprisingly found that the corresponding compounds of cyclobutylamine (B1) and (B2), cyclopentylamine (P1) to (P4) and cyclohexylamine (H1) and (H2) likewise have a very strongly pronounced intrinsic umami taste.
  • With a mixture of the two diastereomers (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid-cyclobutylamide (B2), apart from a very strong umaminote a slightly sweetish impression was also noted.
  • Figure US20100189863A1-20100729-C00026
  • With a mixture of the two diastereomers (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P2) a very much more intensive and clear umami taste was detected at very low concentrations.
  • Figure US20100189863A1-20100729-C00027
  • Also, a mixture of the diastereomers (1R,2R,5S,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P3) and (1S,2R,5S,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide—prepared from (−)p-meth-(2)-ene—which are enantiomeric to (P1) and (P2), exhibited a very strongly pronounced umami taste.
  • Figure US20100189863A1-20100729-C00028
  • With a mixture of the two diastereomers (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclohexylamide (H1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid-cyclohexylamide (H2) an umaminote was also detected, which however developed somewhat more slowly.
  • Figure US20100189863A1-20100729-C00029
  • Most preferred are therefore compounds according to the invention of the Formulae (IVc), (E), (B), (P) and (H), as well as arbitrary mixtures of these substances with one another as well as mixtures with the diastereomers (e.g. IVb) occurring during their synthesis. (E) is understood to denote all above mentioned compounds of the corresponding group (in this case (E1) and (E2)). The comments made as regards (E) apply as appropriate to (B) (in this case to (B1) and (B2)), (P) (in this case to (P1), (P2), (P3) and (P4)) and (H) (in this case to (H1) and (H2)).
  • Compared to other compounds having an umami taste, (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (IVc), the mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) as well as the mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P2) are characterized by a clear umami taste very similar to sodium glutamate (MSG). This is also illustrated in the accompanying spider diagrams, in which an American beef bouillon as base is compared firstly to such a base containing an addition of 5 ppm of (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (IVc) (FIG. 1) or 2 ppm of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) (FIG. 2) or 0.5 ppm of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid-cyclopentylamide (P2) (FIG. 3) respectively, and secondly with such a base containing an addition of 0.05 wt. % of MSG.
  • In our own investigations it has been shown that the compounds of the Formulae (I), (II), (III) or (IV) used according to the invention in foods with a greatly reduced sodium glutamate content or free of sodium glutamate, thus for example in spicy foods such as tomato soup, chicken soup, snacks/nibbles, oven-ready pizzas, potato crisps and popcorn can produce, modify and/or intensify extremely well an umami taste both in the initial taste (impact) as well as in the longer-lasting taste perception, and the taste experience is therefore perceived as pleasant and in many cases is even preferred.
  • According to a further aspect the present invention also relates to compositions, in particular compositions suitable for consumption, including or consisting of a flavor-effective amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as well as one or more further constituents (ingredients) suitable for consumption. As regards the compounds of the Formula (I) used according to the invention and contained in the composition, which is preferably a compound of the Formula (II), (III) or (IV), the comments made above apply as appropriate.
  • The preparations (compositions) according to the invention used for nutritional, oral hygiene or consumption purposes are normally products that are intended to be ingested orally, where they remain in the mouth for a certain time and are then either consumed (for example foodstuffs ready for consumption, see also hereinafter) or are removed from the mouth (for example chewing gums or toothpastes). These products thus include all substances or preparations that are intended to be ingested in the processed, partially processed or unprocessed state by humans. These products in addition also include substances that are added to foodstuffs in the course of their preparation, processing or treatment and are accordingly intended to be ingested by humans.
  • Within the context of the present specification “foodstuffs” are understood in particular to be substances which are intended to be swallowed in the unaltered, prepared or processed state by humans and then digested; foodstuffs are also understood to include coatings, coverings or other types of enclosures which are intended to be swallowed at the same time, or in which swallowing is envisaged. Also, certain products that are normally removed from the mouth (e.g. chewing gums) are understood to be foodstuffs within the context of the present specification, since it is not out of the question that they are at least partially swallowed.
  • A foodstuff that is ready for consumption is understood in this connection to mean a foodstuff that is already fully formulated as regards the substances important for the taste and flavor. The term “foodstuff ready for consumption” also includes beverages, drinks as well as solid or semi-solid foodstuffs ready for consumption. Examples that may be mentioned include deepfrozen products that have to be defrosted before consumption and heated to the consumption temperature. Also, products such as yoghurt or ice-cream and also chewing gum or hard caramels are included as foodstuffs ready for consumption.
  • A mouth care product (also termed oral hygiene product or oral hygiene preparation) within the context of the invention is one of the formulations known to the person skilled in the art for cleaning and care of the oral cavity and throat and also for freshening the breath. Dental care and gum care is specifically included in this connection. Application forms of conventional oral hygiene formulations are in particular crémes, gels, pastes, foams, emulsions, suspensions, aerosols, sprays as well as capsules, granules, pastilles, tablets, sweets or chewing gum, though this list should not be understood as limiting for the purposes of the present invention.
  • Preferred mouthcare products (oral hygiene products) are in particular those in the form of toothpastes, dental crmes, dental gels, dental powders, dental cleaning liquids, dental cleaning foams, mouthwashes, dental crmes and mouthwashes as two-in-one products, lollypops, mouth sprays, flossing agents or dental chewing gums.
  • Chewing gums include in general a chewing gum base, i.e. a chewing composition that becomes plastic on chewing, sugars of various types, sugar substitutes, other sweeteners, sugar alcohols (in particular sorbitol, xylitol, manitol), cooling substances, taste corrigents for unpleasant taste impressions, further taste-altering substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypropionic acid), humectants, thickening agents, emulsifiers, stabilizers, odor corrigents and aroma substances (e.g.: eucalyptus-menthol, cherry, strawberry, grapefruit, vanilla, banana, citrus fruits, peach, blackcurrant, tropical fruits, ginger, coffee, cinnamon, combinations (of the aforementioned aroma substances) with mint aromas such as spearmint and peppermint alone). The combination of the aroma substances with further substances that have cooling, warming and/or mouth-watering properties is also of particular interest
  • In the prior art numerous different chewing gum bases are known, in which connection a distinction should be made between so-called “chewing gum” bases and “bubble gum” bases, the latter being softer so that bubbles of chewing gum can also be produced. Common chewing gum bases include, apart from traditionally used natural resins or chicle from natural latex, nowadays generally elastomers such as polyvinyl acetates (PVA), polyethylenes, (low molecular weight or medium molecular weight) polyisobutenes (PIB), polybutadienes, isobutene-isoprene copolymers (butyl rubber), polyvinyl ethyl ether (PVE), polyvinyl butyl ether, copolymers of vinyl esters and vinyl ethers, styrene-butadiene copolymers (styrene-butadiene rubber, SBR) or vinyl elastomers, for example based on vinyl acetate/vinyl laurate, vinyl acetate/vinyl stearate or ethylene/vinyl acetate, as well as mixtures of the aforementioned elastomers, as described for example in EP 0 242 325, U.S. Pat. No. 4,518,615, U.S. Pat. No. 5,093,136, U.S. Pat. No. 5,266,336, U.S. Pat. No. 5,601,858 or U.S. Pat. No. 6,986,709. In addition chewing gum bases include further constituents such as for example (mineral) fillers, plasticizers, emulsifiers, antioxidants, waxes, fats or fatty oils, such as for example hardened (hydrogenated) vegetable or animal fats, and monoglycerides, diglycerides or triglycerides. Suitable (mineral) fillers are for example calcium carbonate, titanium dioxide, silicon dioxide, talcum, aluminium oxide, dicalcium phosphate, tricalcium phosphate, magnesium hydroxide and their mixtures. Suitable plasticizers and agents for preventing agglutination (detackifiers) are for example lanolin, stearic acid, sodium stearate, ethyl acetate, diacetin (glycerol diacetate), triacetin (glycerol triacetate), triethyl citrate. Suitable waxes are for example paraffin waxes, candelilla wax, carnauba wax, microcrystalline waxes and polyethylene waxes. Suitable emulsifiers are for example phosphatides such as lecithin, monoglycerides and diglycerides of fatty acids, e.g. glycerol monostearate.
  • A number of compositions according to the invention are preferred. Particularly preferred is a (preferably spray-dried) composition which includes, in addition to one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, also one or more solid carrier substances suitable for consumption. Preferred compositions consist of the compound or compounds of the Formulae (I), (II), (III) or (IV) used according to the invention as well as the carrier substance or substances.
  • Advantageous carrier substances in these preferred (preferably spray-dried) compositions according to the invention are silicon dioxide (silicic acid, silica gel), carbohydrates and/or carbohydrate polymers (polysaccharides), cyclodextrins, starches, degraded starches (starch hydrolysates), chemically or physically modified starches, modified celluloses, gum Arabic, ghatti gum, tragacanth, karaya, carragheen, guar seed flour, carob seed flour, alginates, pectin, inulin or xanthan gum. Preferred starch hydrolysates are multidextrins and dextrins.
  • Preferred carrier substances are silicon dioxide, gum Arabic and maltodextrins, wherein maltodextrins with DE values in the range 5 to 20 are in turn preferred. In this connection it is unimportant which plant originally provided the starch for the production of the starch hydrolysates. Maize (corn)-based starches as well as starches obtained from tapioca, rice, wheat or potatoes are suitable and readily available. The carrier substances may at the same time also act as flow auxiliaries (anti-blocking agents), such as for example silicon dioxide.
  • The compositions according to the invention, which apart from the compound or compounds of the Formulae (I), (II), (III) or (IV) according to the invention also contain one or more solid carrier substances, can be produced for example by mechanical mixing processes, in which at the same time a comminution of the particles can also take place, or can be produced by means of spray drying. Preferred are compositions according to the invention which include solid carrier substances and are produced by means of spray drying; as regards spray drying reference is made to U.S. Pat. No. 3,159,585, U.S. Pat. No. 3,971,852, U.S. Pat. No. 4,532,145 or U.S. Pat. No. 5,124,162.
  • Preferred compositions according to the invention containing carrier substances and which have been produced by means of spray drying, have a mean particle size in the range from 30 to 300 μm and a residual moisture of less than or equal to 5 wt. %.
  • The weight ratio of the total mass of the compounds of the Formulae (I) (I), (II), (III) or (IV) used according to the invention to the solid carrier substances suitable for nutritional purposes is preferably in the range from 1:10 to 1:100000, more preferably in the range from 1:100 to 1:20000, particularly preferably in the range from 1:1000 to 1:5000, referred to the dry mass of the composition.
  • The sum of the constituents of (i) compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention, and (ii) the carrier substance or substances in the composition is preferably in the range from 70 to 100 wt. %, more preferably in the range from 85 to 100 wt. %.
  • The invention also relates to a (preferably spray-dried) composition, which apart from one or more compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention as well as (ii) solid carrier substances, includes in addition (iii) one or more aroma compositions, or consists of the aforementioned components.
  • Such an aroma composition within the context of the present invention includes at least one volatile aroma substance (however, this term is understood as not including compounds of the Formula (I)). The volatile aroma substance is in this connection preferably a sensorially active component with a vapour pressure of greater than or equal to 0.01 Pa at 25° C., preferably with a vapour pressure of greater than or equal to 0.025 Pa at 25° C. The majority of volatile aroma substances have a vapour pressure of greater than or equal to 1 Pa at 25° C., and these aroma substances are therefore regarded as preferred for use in compositions according to the invention.
  • Examples of aroma substances which can be a constituent of the aroma composition can be found for example in K. Bauer, D. Garbe and H. Surburg, Common Fragrance and Flavor Materials, 4th. Ed., Wiley-VCH, Weinheim 2001. The following for example may be mentioned: organic acids (saturated and unsaturated), such as for example butyric acid, acetic acid, methylbutyric acid, caproic acid; alcohols (saturated and unsaturated), such as for example ethanol, propylene glycol, octenol, cis-3-hexenol, benzyl alcohol; sulfides and disulfides, such as for example dimethyl sulfide, difurfuryl disulfide, methylthiopropanal; thiols such as for example methylfuranthiol; pyrazines and pyrrolines such as for example methylpyrazine, acetylpyrazine, 2-propionylpyrroline, 2-acetylpyrroline.
  • The aroma compositions can also be used in the form of reaction aromas (Maillard products) and/or extracts and/or essential oils of plants or plant parts and/or fractions thereof.
  • A further preferred composition according to the invention suitable for consumption, which includes one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, is a water-in-oil (W/O) emulsion. In addition to the compound or compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, such an emulsion includes water, an oily phase, one or more W/O emulsifiers, optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
  • Preferably such a composition (W/O emulsion) according to the invention contains
      • 0.01 to 0.1 wt. % of one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention,
      • 5 to 30 wt. %, preferably 8 to 25 wt. % of water,
      • 50 to 90 wt. %, preferably 60 to 80 wt. % of an oily phase,
      • 0.1 to 5 wt. % of an edible W/O emulsifier, and also
      • optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
  • Such a W/O emulsion according to the invention particularly preferably consists of the aforementioned constituents in the aforementioned amounts.
  • The oily phase of such a W/O emulsion according to the invention contains (or consists of) preferably a fatty oil and/or an aroma composition. Preferred are oily phases containing or consisting of a fatty oil and an aroma composition.
  • Edible oils, in particular vegetable oils, are for example suitable as fatty oils. Suitable fatty oils are for example borage oil, thistle oil, groundnut oil, hazelnut oil, coconut oil, pumpkin seed oil, linseed oil, maize germ oil, macadamia nut oil, almond oil, olive oil, palm kernel oil, pecan nut oil, pistachio nut oil, rapeseed oil, rice seed oil, sesame oil, soya oil (soy bean oil), sunflower oil, walnut oil or wheat germ oil, or fractions obtainable therefrom. Liquid neutral esters based on medium chain length fatty acids and glycerol can also be used, such as for example miglyols (for example miglyol 810, miglyol 812). Sunflower oil, palm kernel oil and rapeseed oil are preferred. Furthermore, fractionated coconut oils which principally contain fatty acid residues with 6 to 8 C atoms are preferably used. These are characterized by their taste neutrality as well as by their good oxidation stability.
  • Preferably the edible W/O emulsifier is selected from the group consisting of lecithin (E 322), monoglycerides and diglycerides of edible fatty acids (E 471), acetic acid monoglycerides (E 472a), lactic acid monoglycerides (E 472b), citric acid monoglycerides (E 472c), tartaric acid monoglycerides (E 472d), diacetyltartaric acid monoglycerides (E 472e), and sorbitan monostearate (E 491).
  • Suitable antioxidants and substances which can intensify the antioxidative action are the naturally occurring tocopherols and their derivatives, tocotrienols, flavonoids, ascorbic acids and its salts, alpha-hydroxy acids (for example citric acid, lactic acid, malic acid, tartaric acid) and their Na, K and Ca salts, constituents isolated from plants, or extracts or fractions thereof, for example from tea, green tea, algae, grape seeds, wheat germs, rosemary, oregano, flavonoids, quercetin, phenolic benzylamines. Also suitable as antioxidants are propyl gallate, octyl gallate, dodecyl gallate, butylhydroxyanisole (BHA), butylhy-droxytoluene (BHT), lecithins, monoglycerides and diglycerides of edible fatty acids esterified with citric acid, orthophosphates, and Na, K and Ca salts of monophosphoric acid and ascorbyl palmitate.
  • The W/O emulsions according to the invention are particularly suitable for application to foodstuffs surfaces, the foodstuffs preferably having a water content of at most 10 wt. %, preferably of at most 5 wt. %. In a preferred embodiment the W/O emulsion according to the invention has at the application temperature a sufficiently low viscosity so that it is possible to apply the W/O emulsion by means of spraying. Preferred foodstuffs on the surface of which a W/O emulsion according to the invention can be applied are for example crackers, chips/crisps (for example based on potatoes, maize, grain or bread), extruded nibbles/snack articles (e.g. flips) or pretzel-type articles (e.g. salted sticks or straws). W/O emulsions according to the invention are normally applied to the foodstuffs surfaces in an amount of 0.5 to 6 wt. %, referred to the total weight of the foodstuff.
  • As already mentioned, one aspect of the present invention relates to the use of a compound of the above Formulae (I), (II), (III) or (IV) (in particular a compound specified above as preferred) for the production, modification or intensification of an umami taste.
  • Preferably the compounds of the Formulae (I), (II), (III) or (IV) used according to the invention (in a flavor-active amount) or the compositions according to the invention are employed in (i) ready-to-serve or ready-to-eat preparations or (ii) semi-finished products serving for nutritional or consumption purposes, in particular in preparations with reduced sodium glutamate content or free from sodium glutamate serving for nutritional or consumption purposes.
  • The term “reduced sodium glutamate content” means that the preparation or semi-finished product according to the invention contains significantly less sodium glutamate than is contained in the conventional preparation or semi-finished product; the sodium glutamate content is in this connection 5 to <100 wt. %, preferably 10 to 50 wt. %, particularly preferably 20 to 50 wt. % below the sodium glutamate content of the conventional preparation. If a preparation of semi-finished product according to the invention contains, apart from one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, also sodium glutamate, then the weight ratio of the total amount of compounds of the Formulae (I), (II), (III) or (IV) to sodium glutamate is preferably in the range from 1:1 to 1:200.
  • According to the invention ready-to-serve or ready-to-eat preparations serving for nutritional or consumption purposes contain one or more compounds of the Formulae (I), (II), (III) or (IV) used according to the invention, preferably in an amount in the range from 0.01 ppm to 100 ppm, more preferably in the range from 0.1 ppm to 50 ppm, particularly preferably in the range from 0.1 ppm to 30 ppm, most preferably in the range from 1 ppm to 30 ppm, referred to the total weight of the ready-to-serve or ready-to-eat preparation.
  • Semi-finished products according to the invention serving for nutritional or consumption purposes contain one or more compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention, preferably in an amount in the range from 10 ppm to 800 ppm, more preferably in the range from 25 ppm to 750 ppm, particularly preferably in the range from 50 ppm to 700 ppm, referred to the total weight of the semi-finished product.
  • Particularly relevant are sodium glutamate-reduced preparations according to the invention which contain sodium glutamate, wherein the amount of sodium glutamate is not sufficient to be detected as a satisfactory umami taste in a comparison preparation that does not contain a mixture according to the invention but is of otherwise identical composition (normal sodium glutamate-reduced preparation), and the amount of the mixture according to the invention is sufficient to achieve a satisfactory umami taste impression.
  • Preparations in the context of the invention serving for nutritional or consumption purposes are in particular bakery items (e.g. bread, crackers/biscuits, cakes, other baked items), beverages (e.g. vegetable juices, vegetable juice preparations), instant drinks (e.g. instant vegetable drinks), meat products (e.g. ham, fresh sausage or raw sausage preparations), spicy or marinated fresh or pickled fish products (e.g. surimi), eggs or egg products (dried eggs, egg white, egg yellow), cereal products (e.g. pre-cooked ready-to-serve rice products, rice flour products, millet and sorghum products, raw or pre-cooked noodles and pasta products), dairy produce (e.g. fresh cheese, soft cheese, hard cheese, milk drinks, whey, butter, partially or wholly hydrolysed milk protein-containing products), products from soya protein or other soya bean fractions (e.g. soya milk and products prepared therefrom), soya lecithin-containing preparations, fermented products such as tofu or tempe, or products prepared therefrom, soya sauces), vegetable preparations (e.g ketchups, sauces, dried vegetables, deepfrozen vegetables, pre-cooked vegetables, vegetables pickled in vinegar, vegetable concentrates or pastes, boiled vegetables, potato preparations), nibble/snack articles (e.g. baked or fried potato crisps or potato dough products, bread dough products, extrudates based on maize, rice or groundnuts), products based on fats and oils or emulsions thereof (e.g. mayonnaise, remoulade, spreads, dressings, spice preparations), other ready-to-serve dishes and soups (e.g. dried soups, instant soups, pre-cooked soups), sauces (instant sauces, dried sauces, ready-to-serve sauces), spices, seasonings or spice/seasoning preparations (e.g. mustard preparations, horseradish preparations, marinades), spice mixtures as well as, in particular, seasonings, which are used for example in the snack sector.
  • Particularly preferred are (sodium glutamate-reduced) sodium glutamate-containing semi-finished products or preparations serving for nutritional or consumption purposes, e.g. bakery items (bread, crackers/biscuits, cakes, other bakery items), vegetable juice preparations, meat products (e.g. ham, fresh sausage or raw sausage preparations, spicy or marinated fresh or pickled meat products), eggs or egg products (dried eggs, egg white, egg yellow), cereal products (e.g. pre-cooked ready-to-serve rice products, raw or pre-cooked noodles and pasta products), dairy produce (e.g. fresh cheese, soft cheese, hard cheese, milk drinks, whey, butter, partially or wholly hydrolysed milk protein-containing products), products from soya protein or other soya bean fractions (e.g. soya milk and products prepared therefrom), soya lecithin-containing preparations, fermented products such as tofu or tempe or products prepared therefrom, soya sauces), fish sauces such as for example anchovy sauces, oyster sauces, vegetable preparations (e.g ketchups, sauces, dried vegetables, deepfrozen vegetables, pre-cooked vegetables, vegetables pickled in vinegar, boiled vegetables, potato preparations), nibbles/snack articles (e.g. baked or fried potato crisps or potato paste products, bread dough products, extracts based on maize or groundnuts), products based on fats and oils or emulsions thereof (e.g. mayonnaise, remoulades, dressings, spice preparations), ready-to-serve dishes, soups (e.g. dried soups, instant soups, pre-cooked soups), soup or bouillon cubes, sauces (instant sauces, dried sauces, ready-to-serve sauces), spices, relishes, condiments, spice mixtures as well as, in particular, seasonings, which are used for example in the snack sector.
  • The preparations in the context of the invention can also be in the form of capsules, tablets (non-coated as well as coated tablets, e.g. coatings resistant to gastric juices), pills, granules, pellets, solid mixtures, dispersions in liquid phases, as emulsions, as powders, as solutions, as pastes or as other preparations that can be swallowed or chewed, for example as dietary and nutritional supplements.
  • The semi-finished products according to the invention serve as a rule for the production of ready-to-serve or ready-to-eat preparations serving for nutritional or consumption purposes.
  • In particular semi-finished products according to the invention and serving for nutritional or consumption purposes can be used to intensify the umami taste of nutritional and food products with reduced sodium glutamate content, and can also be used directly as spices for the industrial or non-industrial preparation of nutritional and/or food products.
  • Semi-finished products according to the invention preferably contain a total amount of 10 ppm to 800 ppm, more preferably 25 ppm to 750 ppm and in particular 50 ppm to 700 ppm of compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention,
  • contain no sodium glutamate or an amount of 0.00001 wt. % to 10 wt. %, preferably 0.0001 wt. % to 5 wt. % and in particular 0.001 wt. % to 2 wt. % of sodium glutamate,
    and optionally contain an amount of 0.0001 wt. % to 90 wt. %, preferably 0.001 wt. % to 30 wt. % of an aroma composition, in each case referred to the total weight of the semi-finished products.
  • The preparations or semi-finished products according to the invention are preferably produced by dissolving and mixing the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention in mixtures of ethanol and optionally demineralized and/or purified water, following which the solutions are converted by a drying process, preferably a spray drying, vacuum freeze drying, reverse osmosis, vaporisation or other concentration process or a combination of the aforementioned processes, into an (at least almost) solid preparation. In this connection the drying can take place with the assistance of carrier substances (for example starch, starch derivatives, maltodextrin, silica gel, see above) or auxiliary substances (for example natural gums, stabilising agents). The drying is preferably carried out by means of spray drying or vacuum freeze drying.
  • Preferred preparations or semi-finished products according to the invention are spices, spice mixtures, condiments, soup cubes, instant soups, instant sauces, vegetarian ready-cooked dishes, meat-containing ready-cooked dishes, fish sauces such as for example anchovy sauces, oyster sauces, and soya sauces.
  • According to a further preferred embodiment, for the production of preparations or semi-finished products according to the invention compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention as well as optionally other constituents are first of all incorporated into emulsions, into liposomes (for example obtained from phosphatidyl choline), into microspheres, into nanospheres or also into capsules, granules or extrudates of a matrix suitable for foodstuffs and luxury foods (for example from starch, starch derivatives, cellulose or cellulose derivatives such as hydroxypropylcellulose, other polysaccharides such as alginate, natural fats, natural waxes such as beeswax or carnauba wax, or from proteins such as gelatins).
  • In a further preferred production process the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are complexed with one or more suitable complex-forming agents, for example with cyclodextrins or cyclodextrin-derivatives, preferably alpha-cyclodextrin or beta-cyclodextrin, and are employed in this complexed form.
  • Particularly preferred are preparations according to the invention in which the matrix is chosen so that the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are released in a delayed manner from the matrix, so that a long-lasting action is obtained. In this case for example natural fats, natural waxes (for example beeswax, carnauba wax), or also natural bulking substances (wheat fibres, apple fibres, oat fibres, orange fibres) can be used as matrix.
  • Further constituents (ingredients) of a ready-to-eat preparation or semi-finished product according to the invention serving for nutritional or consumption purposes can be conventional base substances, auxiliary substances and additives for nutritional or consumption purposes, for example water, mixtures of fresh or processed, vegetable or animal base substances or raw materials (for example raw, roasted, dried, fermented, smoked and/or cooked meat, bones, cartilage, fish, vegetables, herbs, nuts, vegetable juices or pastes or mixtures thereof), digestible or indigestible carbohydrates (e.g. sucrose, maltose, fructose, glucose, dextrins, amylose, amylopectin, inulin, xylans, cellulose, tagatose), sugar alcohols (e.g. sorbitol, erythritol), natural or hardened fats (e.g. suet, lard, palm oil, coconut butter, hardened vegetable oil), oils (for example sunflower oil, groundnut oil, maize seed oil, olive oil, fish oil, soya oil, sesame oil), fatty acids or their salts (e.g. potassium stearate), proteinaceous or non-proteinaceous amino acids and related compounds (for example γ-aminobutyric acid, taurine), peptides (for example glutathione), natural or processed proteins (for example gelatins), enzymes (for example peptidases), nucleic acids, nucleotides, taste corrigents for unpleasant taste impressions, further taste modulators for further, generally unpleasant taste impressions, other taste-modulating substances (for example inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phen-oxypropionic acid), emulsifiiers (for example lecithins, diacyl glycerols, gum arabic), stabilizers (for example carrageen, alginate), preservatives (for example benzoic acid and its salts, sorbic acid and its salts), antioxidants (for example tocopherol, ascorbic acid), chelating agents (for example citric acid), organic or inorganic acidifying agents (for example acetic acid, phosphoric acid), additional bitter principles (for example quinine, caffeine, limonine, amarogentin, humolones, lupolones, catechols, tannins), substances preventing enzymatic browning (for example sulfite, ascorbic acid), essential oils, plant extracts, natural or synthetic dyes or coloured pigments (for example carotinoids, flavonoids, anthocyans, chlorophyll and derivatives thereof), spices, trigeminally-active substances or plant extracts containing such trigeminally-active substances, synthetic, natural or natural-identical aroma substances or fragrances, as well as olfactory corrigents.
  • Preferably compositions, preparations or semi-finished products according to the invention contain an aroma composition in order to round off and refine the taste and/or the smell. A composition according to the invention which contains as further constituents a solid carrier substance and an aroma composition, has already been described in more detail above. Suitable aroma compositions contain for example synthetic, natural or natural-identical aroma substances, fragrances and flavor substances, reaction aromas, smoke aromas or other aroma-imparting preparations (for example protein (partial) hydrolysates, grill aromas, plant extracts, spices, spice preparations, vegetables and/or vegetable preparations) as well as suitable auxiliary substances and carrier substances. In particular, suitable in this case are the aroma compositions not according to the invention or their constituents which produce a roasted, fish/meat-like (in particular chicken, fish, seafood, beef, pork, lamb, mutton, goat), vegetable-like (in particular tomato, onion, garlic, celery, leek, mushroom, aubergine, seaweed), spicy (in particular black and white pepper, chilli, paprika, cardamom, nutmeg, allspice, mustard and mustard products), roasted, yeast-like, boiled, fatty/oily, salty and/or sharp aroma impression and can thus intensify the spicy impression. As a rule the aroma compositions contain more than one of the aforementioned ingredients.
  • In a further modification of the present invention the compounds of the Formulae (I), (II), (III) or (IV) to be used according to the invention are employed in the compositions, preparations and semi-finished products according to the invention in combination with at least one (further, not per se according to the invention) substance in order to mask or reduce an unpleasant (bitter, metallic, chalky, acidic, astringent) taste impression or to intensify or produce a pleasant taste impression (sweet, salty, umami). In this way an intensification of the taste, in particular the umami taste, can be achieved. These further substances can be chosen from the following list, without however restricting the invention: monosodium glutamate, glutamic acid, nucleotides (for example adenosine-5′-monophosphate, cytidine-5′-monophosphate, inosine-5′-monophosphate, guanosine-5′-monophosphate) or their pharmaceutically acceptable salts, lactisols, hydroxyflavanones (for example eriodictyol, homoeriodictyol or their sodium salts), in particular according to EP 1 258 200, hydroxybenzoic acid amides (for example 2,4-dihydroxybenzoic acid vanillylamide, 4-hydroxybenzoic acid vanillylamide), mixtures of whey proteins with lecithins, yeast extracts, plant hydrolysates, powdered vegetables (for example onion powder, tomato powder), plant extracts (for example from lovage or from mushrooms such as shiitake), seaweed and mineral salt mixtures.
  • Modulating aroma substances and/or flavor substances are preferably selected from the group consisting of adenosine-5′-monophosphate, cytidine-5′-monophosphate, inosine-5′-monophosphate, and their pharmaceutically acceptable salts; lactisols; 2,4-dihydroxybenzoic acid; 3-hydroxybenzoic acid; sodium salts, preferably sodium chloride, sodium lactate, sodium citrate, sodium acetate, sodium gluconate; hydroxyflavonones, such as for example eriodictyol, homoeriodictyol and their sodium salts; hydroxybenzoic acid amides, such as for example 2,4-dihydroxybenzoic acid vanillylamide, 2,4-dihydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide, 2,4,6-trihydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide, 2-hydroxy-benzoic acid-N-4-(hydroxy-3-methoxybenzyl)amide, 4-hydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide, 2,4-dihydroxybenzoic acid-N-(4-hydroxy-3-methoxybenzyl)amide monosodium salt, 2,4-dihydroxybenzoic acid-N-2-(4-hydroxy-3-methoxyphenyl)ethylamide, 2,4-dihydroxybenzoic acid-N-(4-hydroxy-3-ethoxybenzyl)amide, 2,4-dihydroxybenzoic acid-N-(3,4-dihydroxybenzyl)amide and 2-hydroxy-5-methoxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]amide; 4-hydroxybenzoic acid vanillylamide (in particular as described in WO 2006/024587, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application); hydroxydeoxybenzoins, such as for example 2-(4-hydroxy-3-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone, 1-(2,4-dihydroxyphenyl)-2-(4-hydroxy-3-methoxyphenyl)ethanone, 1-(2-hydroxy-4-methoxyphenyl)-2-(4-hydroxy-3-methoxyphenyl)ethanone) (in particular those as described in WO 2006/106023, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application); hydroxyphenylalkanediones, such as for example ginger dione-[2], gingerdione-[3], gingerdione-[4], dehydrogingerdione-[2], dehydrogingerdione-[3], dehydrogingerdione-[4]) (in particular those as described in WO 2007/003527, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application); diacetyl trimers (in particular those as described in WO 2006/058893, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application); γ-aminobutyric acids (in particular those as described in WO 2005/096841, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application); and divanillins (in particular divanillin as described in WO 2004/078302, which as regards the corresponding compounds disclosed therein is on course to be referred to as a constituent part of the present application). It is also possible to include saliva-inducing/mouth-watering substances, preferably pellitorin, more preferably trans-pellitorin.
  • From the preceding text it follows that a further aspect of the present invention is also a process for generating, modifying or intensifying a flavor, in particular an umami flavor, in (i) a ready-for-use or ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes. Such a process according to the invention includes the following step:
  • Mixing a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) or a composition according to the invention with one or more further constituents of the (i) ready-to-eat preparation or of the (ii) semi-finished product,
  • or
    applying a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) or of a composition according to the invention to one or more further constituents of the (i) ready-to-eat preparation or of the (ii) semi-finished product, or
    embedding a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) or of a composition according to the invention in a shell or matrix material.
  • A further aspect of the present invention relates to new compounds of the Formulae (I), (II), (III) and (IV). In particular, the compounds already known from the document US 2004/0209859 A1, in particular the individual compounds listed hereinbefore, insofar as they fall under Formula (I), are not the subject-matter of the present invention, although their use is (see in this connection the accompanying patent claims). Preferably the compounds mentioned in the description, in particular in paragraphs [0059] to [0120], and the compounds mentioned in the examples of US 2004/0209859 A1, in particular in Examples 38 and 49, are not the subject-matter of the present invention. Preferably also the products of the syntheses described in the examples, in particular in Examples 38 and 49, are not the subject-matter of the present invention. It is provisionally preferred that all individual compounds mentioned hereinbefore in the disclosures of document US 2004/0209859 A1 are not the subject-matter of the present invention, as well as those in which it is not clear whether they have actually been disclosed.
  • A further aspect of the present invention relates to a process for the production of a compound of the Formulae (IVa), (IVc), (E), (B), (P) or (H) comprising the following steps:
      • reacting a compound of the Formula (V),
  • Figure US20100189863A1-20100729-C00030
  • with a compound capable of forming a carbene, preferably in a rhodium-catalyzed or copper-catalyzed reaction, wherein a compound of the Formula (VI) is formed (and in addition normally further diastereomers)
  • Figure US20100189863A1-20100729-C00031
  • where R1 denotes alkyl,
      • saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
  • Figure US20100189863A1-20100729-C00032
      • conversion of the compound of the Formula (VII) to the corresponding acid chloride (by reaction with a compound suitable for the production of acid chlorides) and subsequent reaction of the acid chloride with a compound of the formula NH2-Rb,
        wherein R1, R7 and Rb have the meanings given above.
  • Compounds of the Formula (V) can be prepared in a similar manner to that described in Roczniki Chemii Ann. Soc. Chim. Polonorum 1976, 50, 1901-1908.
  • A compound capable of forming a carbine, with which a compound of the Formula (V) is reacted, is preferably an alkyl diazoacetate. Particularly preferred in this connection is ethyl diazoacetate (diazoacetic acid ester). A compound of the Formula (V) reacts with ethyl diazoacetate to form a compound of the Formula (VI), in which Rc denotes ethyl.
  • Preferred compounds suitable for the preparation of acid chlorides are oxalyl chloride or thionyl chloride.
  • Preferably, in a preparation process according to the invention R1 denotes methyl, R7 denotes isopropyl and Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • The invention will now be described in more detail hereinafter with the aid of examples. Further aspects of the present invention are disclosed in the accompanying claims.
  • DESCRIPTION OF THE FIGURES
  • The test panel evaluated the strength of the specified flavors in each case by awarding points on a scale from 0 (no corresponding taste) to 6 (very pronounced corresponding taste). The mean values of the respective scores are shown.
  • FIG. 1: Taste comparison of (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide with sodium glutamate.
  • The taste of a 0.5% American beef extract as base (continuous, pale line) was compared on the basis of an evaluation by a panel of trained testers with the taste firstly of such a base to which 5 ppm of (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide had been added (continuous, dark line), and secondly of such a base to which 0.05 wt. % of MSG had been added (dotted line).
  • FIG. 2: Taste comparison of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) with sodium glutamate.
  • The taste of a 0.5% American beef extract as base (continuous, pale line) was compared on the basis of an evaluation by a panel of trained testers to the taste firstly of such a base to which 2 ppm of a mixture of 1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (B2) had been added (continuous, dark line), and secondly of such a base to which 0.05 wt. % of MSG had been added (dotted line).
  • FIG. 3: Taste comparison of a mixture of (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid-cyclopentylamide (P2) with sodium glutamate.
  • The taste of a 0.5 wt. % American beef extract as base (continuous, pale line) was compared on the basis of an evaluation by a panel of trained testers with the taste firstly of such a base to which 0.5 ppm of a mixture of (1S,2S,5R,6R,7S)-2-Isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P1) and (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (P2) had been added (continuous, dark line), and secondly of such a base to which 0.05 wt. % of MSG had been added (dotted line).
  • EXAMPLES Synthesis Example 1 (2S,5R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide Synthesis Example 1a (2S,5R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethyl ester
  • 98.4 g of a technical mixture of menthenes (60% (+)-p-menth-2-ene, 16.4% p-3-menthene) and 120 mg of rhodium(II) acetate dimer dihydrate are placed in a 500 ml three-necked flask equipped with magnetic stirrer, contact thermometer and high-efficiency condenser. 40.8 g of a 35% solution of ethyl diazoacetate (diazoacetic acid ethylester) in dichloromethane are added at 40° C. over 4 hours while stirring. The reaction mixture is stirred for a further 2 hours at 40° C., and the crude product is washed twice with 75 ml of water, dried over sodium sulfate, and excess menthene is distilled off under vacuum.
  • The crude product is purified by chromatography on 90 g of silica gel (diethyl-ether/hexane=1/20). 1.4 g of a product fraction containing 92% of 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethyl ester and 1.9 g of a second fraction containing 66% of the desired ester are obtained.
  • Synthesis Example 1b (2S,5R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid
  • 1.9 g of 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethyl ester (66%) from synthesis example 1a are boiled under reflux for 3 hours with 20 ml of 10% sodium hydroxide solution. 25 ml of 10% hydrochloric acid are added and the mixture is extracted twice with 50 ml of diethyl ether. The organic phases are dried with sodium sulfate and the solvent is distilled off under vacuum. 1.37 g of a crude product containing 69% of the 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid isomers are obtained.
  • Synthesis Example 1c (2S,5R)-2-Isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide
  • 1.37 g of 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid from Synthesis Example 1b are dissolved in 30 ml of diethyl ether and 1.07 g of oxalyl chloride are added at room temperature while stirring. The reaction mixture is stirred for 2 hours at room temperature and the solvent is removed under vacuum.
  • The crude acid chloride is dissolved in dichloromethane. 5.7 ml of ethylamine solution (70% in water) are added dropwise while stirring. The reaction mixture is stirred for 16 hours at room temperature, washed twice with 10 ml of water, dried over sodium sulfate and the solvent is distilled off under vacuum.
  • The crude product is purified by chromatography on 60 g of silica gel (diethyl ether/hexane=1/4). The following fractions are obtained: A) 0.63 g of 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide with a purity of >98% (ratio of the (1R,2S,5R,6S,7R) isomer to the (1S,2S,5R,6R,7S) isomer ca. 1:1), B) 250 mg with the following composition: 2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide isomer (1S,2S,5R,6R,7S) 34.3%, isomer (1R,2S,5R,6S,7R) 53.5%, two isomers of 1-isopropyl-4-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide 4.4% and 3.1%, and C) 230 mg with 80% of N-ethyl-2-(4-isopropyl-1-methyl-cyclohex-2-enyl)-acetamide.
  • The fraction B is purified further by preparative HPLC.
  • Preparative HPLC:
  • Column: Grom sapphire 110 Si, 5 μm 125+150×20 mm
  • Eluent: Heptane/MTBE (65/35)
  • Mode: isocratic
  • Flow rate: 15 ml/min
  • Pressure: 31 bar
  • Temperature: Room temperature
  • Detection: 265 nm
  • Isolates from the preparative HPLC:
  • Fraction 1: 5 mg
  • 1-isopropyl-4-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide
  • Analysis data:
  • MS (EI): m/z=29 (13%), 41 (12), 55 (12), 72 (25), 81 (12), 87 (100), 88 (28), 95 (15), 109 (12), 136 (12), 223 (7, M+).
  • Fraction 2: 34 mg
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide (Compound of the Formula (IVc))
  • Analysis data:
  • 1H-NMR (400 MHz, CDCl3): δ=0.56 (mc, 1H), 0.73-0.84 (m, 1H), 0.91 (d, J=6.7 Hz, 3H), 0.94 (d, J=6.6 Hz, 3H), 1.01 (t, J=4.5 Hz, 1H), 1.09 (d, J=6.8 Hz, 3H), 1.14 (t, J=7.2 Hz, 3H), 1.31 (ddd, J=1.8, 4.2, 9.2 Hz, 1H), 1.31-1.41 (m, 1H), 1.44-1.56 (m, 3H), 1.57-1.65 (m, 2H), 3.29 (q, J=7.2 Hz, 1H), 3.31 (q, J=7.2 Hz, 1 5.46 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=15.1 (CH3), 20.5 (CH3), 20.7 (CH3), 23.4 (CH3), 24.8 (CH2), 25.6 (CH), 26.0 (CH), 27.4 (CH), 30.4 (CH), 32.7 (CH2), 33.6 (CH), 34.5 (CH2), 39.9 (CH) 173.4 (C═O).
  • MS (EI): m/z=29 (32%), 67 (32), 72 (38), 87 (99), 88 (40), 95 (29), 109 (55), 138 (62), 180 (100), 223 (10, NC).
  • Fraction δ: 15 mg
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide
  • Analysis data:
  • 1H-NMR (400 MHz, CDCl3): δ=0.53 (mc, 1H), 0.91 (d, J=6.8 Hz, 3H), 0.93 (d, J=6.8 Hz, 3H), 0.97 (d, J=6.6 Hz, 3H), 0.98 (mc, 1H), 1.14 (t, J=7.3 Hz, 3H), 1.20-1.32 (m, 2H), 1.35-1.53 (m, 3H), 1.54-1.71 (m, 2H), 1.84-1.94 (m, 1H), 3.29 (mc, 2H), 5.63 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=14.9 (CH3), 19.2 (CH3), 19.9 (CH3), 21.4 (CH3), 25.2 (CH), 25.3 (CH), 26.1 (CH2), 28.2 (CH), 28.7 (CH), 28.7 (CH2), 33.2 (CH), 34.4 (CH2), 41.8 (CH), 173.6 (C═O).
  • MS (EI): m/z=29 (26%), 55 (26), 72 (28), 81 (37), 87 (70), 95 (29), 109 (32), 138 (70), 180 (100), 223 (17, M+).
  • Synthesis Examples 2-6 Synthesis of further substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides General Synthesis Procedure Step a: Cyclopropanecarboxylic Acid Ethyl Ester by Addition of Ethyl Diazoacetate to Alkenes
  • 0.15 mole of alkene and 0.45 mmol of rhodium(II) acetate (dimer, dihydrate) are added to 200 ml of dichloromethane. 0.15 mole of ethyl diazoacetate is added at 40° C. over a period of 6 hours while stirring. The reaction mixture is stirred for a further 2 hours, washed twice with 100 ml of water, dried over sodium sulfate, and the solvent is distilled off under vacuum.
  • The residue is filtered over 25 g of silica gel (diethyl ether/pentane=1/5). After removing the solvent the crude product is used for the saponification corresponding to the general procedure described in Synthesis Example 2b.
  • Step b: Cyclopropanecarboxylic Acid by Saponification of the Cyclopropanecarboxylic Acid Ethyl Ester
  • 100 mmol of crude cyclopropanecarboxylic acid ester from Synthesis Example 2a are boiled under reflux in 100 ml of sodium hydroxide solution (10%) and 30 ml of ethanol for 3 hours. The reaction mixture is diluted with 100 ml of water and extracted twice, each time with 100 ml of diethyl ether.
  • 120 ml of hydrochloric acid (10%) is added to the aqueous phase, which is extracted three times with in each case 100 ml of diethyl ether. The organic phase is dried with sodium sulfate and the solvent is distilled off under vacuum.
  • The crude material is used for the preparation of the acid chloride and the subsequent aminol ysis to the ethylamide corresponding to the general procedure in Synthesis Example 2c.
  • Step c: Preparation of the Acid Chloride and Subsequent Aminolysis to the Alkylamide
  • 50 mmol of crude cyclopropanecarboxylic acid from Synthesis Example 2b are dissolved in 100 ml of diethyl ether and 300 μl of DMF are added. 60 mmol of oxalyl chloride are added dropwise at 25° C. over a period of 30 minutes while stirring. The reaction mixture is stirred for 16 hours at room temperature.
  • 200 mmol of alkylamine (70% in water) are added at 20° C. The reaction mixture is stirred for 4 hours at room temperature, diluted with 100 ml of diethyl ether, washed with respectively 50 ml of water, hydrochloric acid (10%), saturated sodium hydrogen carbonate solution and saturated sodium chloride solution, dried over sodium sulfate, and the solvent is removed under vacuum.
  • The crude product is purified by chromatography on silica gel (diethyl ether/pentane=½).
  • With purities <95% (according to GC), the product is purified further by preparative HPLC:
  • Column: Chromsil Sapphire 5 μm 125×20 mm
  • Eluent: 65% MeOH/35% water
  • Mode: isocratic
  • Flow rate: 80 ml/min
  • Pressure: 135 bar
  • Temperature: RT
  • Detection: 270 nm/R1
  • Synthesis Example 2 Tricyclo[3.2.1.02,4]octane-3-carboxylic acid N-ethylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, norbornene being used as alkene.
  • Analysis data:
  • 1H-NMR (400 MHz, CDCl3): δ=0.68 (dquint, J=˜1, 10.8 Hz, 1H), 0.88 (dquint, J=2.1, 10.8 Hz, 1H), 1.12 (t, J=7.3 Hz, 3H), 1.23 (t, J=2.5 Hz, 1H), 1.30-1.36 (m, 4H), 1.38-1.48 (m, 2H), 2.33 (s, 2H), 3.27 (dq, J=5.6, 7.3 Hz, 1.8H), 3.36 (dq, J=6.1, 7.3 Hz, 0.2H), 5.53 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=15.0 (CH3), 18.4 (CH), 24.6 (CH), 28.7 (CH2), 28.9 (CH2), 34.4 (CH2), 35.8 (CH), 172.9 (C═O).
  • MS (EI): m/z=29 (42%), 44 (33), 55 (30%), 72 (45), 79 (69), 87 (55), 91 (32), 124 (47), 150 (40), 179 (100, M+).
  • Synthesis Example 3 Bicyclo[4.1.0]heptane-7-carboxylic acid N-ethylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, cyclohexene being used as alkene.
  • Analysis data:
  • 1H-NMR (400 MHz, CDCl3): δ=1.07 (t, J=4.3 Hz, 1H), 1.14 (t, J=7.3 Hz, 3H), 1.12-1.35 (m, 4H), 1.54 (mc, 2H), 1.60-1.68 (m, 2H), 1.86-2.00 (m, 2H), 3.29 (dq, J=5.6, 7.3 Hz, 1.86), 3.36 (dq, J=6, 7.3 Hz, 0.14H), 5.61 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=15.0 (CH3), 20.4 (CH), 21.2 (CH2), 22.9 (CH2), 28.0 (CH), 34.5 (CH2), 173.5 (C═O).
  • MS (EI): m/z=29 (23%), 55 (38), 67 (26), 72 (20), 81 (22), 87 (20), 95 (27), 96 (20), 124 (100), 167 (59, M+).
  • Synthesis Example 4 2-isopropyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, 1-isopropylcyclohex-2-ene being used as alkene.
  • Analysis data:
  • MS (EI): m/z=29 (22%), 41 (26), 55 (20), 67 (22), 72 (43), 81 (30), 87 (95), 95 (43), 124 (27), 166 (100), 209 (12, M+).
  • Synthesis Example 5 2,4-dimethyl-bicyclo[4.1.0]heptane-7-carboxylic acid ethylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, 1,3-dimethylcyclohex-4-ene being used as alkene.
  • Analysis data:
  • 1H-NMR (400 MHz, C6D6): δ=0.36 (q, J=12.1 Hz, 1H), 0.77 (d, J=4.3 Hz, 1H), 0.79 (d, J=6.4 Hz, 3H), 0.84 (t, J=7.2 Hz, 3H), 0.91-0.98 (m, 1H), 1.00 (d, J=6.9 Hz, 3H), 1.10 (ddd, J=13.3, 11.9, 5.0 Hz, 1H), 1.25 (ddd, J=12.7, 5.2, 1.9 Hz, 1H), 1.48-1.58 (m, 2H), 1.78 (mc, 1H), 1.86 (mc, 1H), 3.13 (mc, 1H), 4.90 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=15.3 (CH3), 22.7 (CH3), 23.1 (CH), 23.7 (CH3), 26.5 (CH), 27.1 (CH), 28.3 (CH), 31.6 (CH), 31.9 (CH2), 34.5 (CH2), 41.5 (CH2), 173.5 (C═O).
  • MS (EI): m/z=29 (28%), 55 (37), 67 (24), 72 (40), 81 (40), 87 (100), 88 (31), 124 (48), 138 (46), 195 (31, M+).
  • Synthesis Example 6 Cyclopropanecarboxylic acid N-ethylamide (not according to the invention)
  • 7.32 g of cyclopropanecarboxylic acid chloride (Aldrich, 70 mmol) are added to 100 ml of dichloromethane and 22.3 ml of ethylamine (70% solution in water) are slowly added while stirring. The reaction mixture is stirred for 14 hours at room temperature, diluted with 150 ml of diethyl ether, the organic phase is washed twice with 50 ml of water and 50 ml of saturated sodium chloride solution, dried over sodium sulfate, and the solvent is distilled off under reduced pressure. 5.2 g of cyclopropanecarboxylic acid N-ethylamide are obtained.
  • Analysis data:
  • 1H-NMR (400 MHz, CDCl3): δ=0.69-0.74 (m, 2H), 0.93-0.97 (m, 2H), 1.15 (t, J=7.3 Hz, 3H), 1.34 (mc, 1H), 3.31 (dq, J=5.6, 7.3 Hz, 2H), 5.86 (sb, 1H).
  • 13C-NMR (100 MHz, CDCl3): δ=6.9 (CH2), 14.7 (CH), 15.0 (CH3), 34.5 (CH2), 173.5 (C═O).
  • MS (EI): m/z=27 (11%), 29 (24), 39 (24), 41 (51), 44 (27), 55 (11), 69 (100), 72 (10), 51 (98), 112 (43, M−1+).
  • Synthesis Example 7 (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide/(1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, using (3S,6R)-3-isopropyl-6-methylcyclohexene as alkene and cyclobutylamine as amine. After crystallization an approx. 1:1 mixture of the two diastereomers was obtained.
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (major diastereomer)
  • MS (EI): m/z=41 (41), 43 (66), 55 (73), 69 (36), 81 (56), 93 (76), 95 (100), 135 (63), 179 (95), 221 (91), 249 (0.3, M+).
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclobutylamide (minor diastereomer)
  • MS (EI): m/z=43 (55), 55 (62), 81 (50), 93 (79), 95 (100), 135 (62), 136 (47), 178 (47), 179 (46), 221 (76), 249 (0.7, M+).
  • Synthesis Example 8 (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide/(1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, (3S,6R)-3-isopropyl-6-methyl-cyclohexene being used as alkene and cyclopentylamine being used as amine. After crystallization an approx. 2:3 mixture of the two diastereomers was obtained.
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (major diastereomer)
  • MS (EI): m/z=41 (43), 55 (30), 60 (36), 69 (45), 81 (28), 95 (36), 127 (49), 178 (53), 220 (100), 263 (31, M+).
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclopentylamide (minor diastereomer)
  • MS (EI): m/z=41 (48), 55 (30), 60 (51), 67 (30), 69 (59), 95 (34), 109 (44), 127 (79), 178 (46), 220 (100), 263 (29, M+).
  • Synthesis Example 9 (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclohexylamide/(1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclohexylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, using (3S,6R)-3-isopropyl-6-methylcyclohexene as alkene and cyclohexylamine as amine. After crystallization an approx. 2:3 mixture of the two diastereomers was obtained.
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclohexylamide (major diastereomer)
  • MS (EI): m/z=41 (31), 55 (51), 60 (33), 81 (30), 83 (29), 95 (33), 109 (27), 141 (38), 192 (45), 234 (100), 277 (20, M+).
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid cyclohexylamide (minor diastereomer)
  • MS (EI): m/z=41 (36), 55 (59), 60 (52), 67 (29), 83 (38), 95 (35), 109 (40), 141 (73), 192 (40), 234 (100), 277 (15, M+).
  • Synthesis Example 10 (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid isopropylamide/(1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid isopropylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, using (3S,6R)-3-isopropyl-6-methyl-cyclohexene as alkene and isopropylamine as amine. After crystallization an approx. 2:3 mixture of the two diastereomers was obtained.
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid isopropylamide (major diastereomer)
  • MS (EI): m/z=41 (34), 43 (60), 55 (25), 81 (31), 95 (30), 101 (60), 109 (30), 152 (61), 194 (100), 237 (31, M+).
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid isopropylamide (minor diastereomer)
  • MS (EI): m/z=41 (37), 43 (81), 55 (28), 67 (28), 86 (35), 95 (31), 101 (93), 109 (51), 152 (59), 194 (100), 237 (26, M+).
  • Synthesis Example 11 (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid dimethylamide/(1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid dimethylamide
  • The aforementioned substance was prepared according to the general synthesis procedure, using (3S,6R)-3-isopropyl-6-methylcyclohexene as alkene and dimethylamine as amine. After preparative HPLC an approx. 1:2 mixture of the two diastereomers is obtained.
  • (1S,2S,5R,6R,7S)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid dimethylamide (major diastereomer)
  • MS (EI): m/z=41 (25), 55 (21), 72 (100), 81 (17), 87 (98), 88 (26), 95 (23), 109 (28), 138 (54), 180 (93), 223 (16, M+).
  • (1R,2S,5R,6S,7R)-2-isopropyl-5-methyl-bicyclo[4.1.0]heptane-7-carboxylic acid dimethylamide (minor diastereomer)
  • MS (EI): m/z=41 (20), 55 (22), 72 (75), 81 (24), 87 (58), 95 (20), 109 (16), 138 (56), 180 (100), 223 (23, M+).
  • Example 1 Spray-Dried Composition for Producing an Umami Flavor
  • 1.1 Constituent Amount
    Compound of the Formula (IVc)  1 g
    Maltodextrin 99 g
    1.2 Constituent Amount
    Mixture of the (1R,2S,5R,6S,7R) isomer and the  2 g
    (1S,2S,5R,6R,7S) isomer of 2-isopropyl-5-methyl-
    bicyclo[4.1.0]heptane-7-carboxylic acid
    ethylamide (Fraction A from Synthesis Example 1c)
    Maltodextrin 98 g
  • The constituents are dissolved in a mixture of ethanol and demineralized water and then spray-dried.
  • Example 2 Spice Containing a Compound for Producing an Umami Flavor as Well as an Aroma Composition
  • Part Constituent Amount
    A Compound of the Formula (IVc) 0.01 g
    Sodium chloride   15 g
    B Ground mustard seeds   5 g
    Mustard aroma  0.1 g
  • Part A was weighed out. 290 ml of water were placed in a vessel and Part A was added and dissolved while stirring. The solution is diluted with water to 1.84 kg (pH 6.0) and then freeze-dried (eutectic point: −15° C.; operating vacuum: 0.52 mbar; shelf temperature: −5° C. to +25° C.). The product is mixed with ground mustard seeds and the mustard aroma from Part B and formulated into a spice.
  • Example 3 Umami Type Reaction Aroma
  • Constituent Amount [g]
    L-alanine 41
    L-aspartic acid 123
    Succinic acid 4.7
    Calcium chloride dihydrate 7
    L-cysteine•HCl monohydrate 11
    Dipotassium phosphate 6
    Ground fructose 1
    L-isoleucine 1.6
    Potassium chloride 228
    L-leucine 1.6
    L-lysine•HCl 3.6
    Magnesium chloride hexahydrate 19
    Maltodextrin 49
    L-phenylalanine 2
    L-proline 74
    L-serine 6.5
    L-threonine 3
    L-valine 9
    Water 399
    Compound of the Formula (IVc), 10
    10 wt. % in EtOH
  • All components are mixed at 40° C. and then heated at 85° C. for ten minutes (reflux reaction). After cooling to 40° C. the reaction mixture is adjusted to pH 5 with potassium hydroxide solution. This umami reaction aroma instead of the pure compound (IVc) was incorporated into the bouillon preparations C and D of application Example 5, 12 g of the umami reaction aroma being used in preparation C and 28 g of the umami reaction aroma being used in preparation D.
  • Application Example 1 Instant Soup, Cream of Leek Type
  • Preparation B Preparation C Preparation D
    Comparison according to according to according to
    Constituent Preparation A the invention the invention the invention
    Potato starch 20.0 g 21.0 g 21.0 g 21.0 g
    Powdered fat 25.0 g 26.0 g 26.0 g 26.0 g
    Lactose 20.0 g 21.0 g 21.0 g 21.0 g
    Maltodextrin 11.73 g 11.727 g 11.70 g 11.43 g
    Cooking salt 8.0 g 8.0 g 8.0 g 8.0 g
    Sodium glutamate 3.0 g
    Spinach powder 2.0 g 2.0 g 2.0 g 2.0 g
    Green leek powder 2.0 g 2.0 g 2.0 g 2.0 g
    Citric acid, as 0.3 g 0.3 g 0.3 g 0.3 g
    powder
    Hardened 3.0 g 3.0 g 3.0 g 3.0 g
    vegetable fat
    Freeze-dried leek 1.0 g 1.0 g 1.0 g 1.0 g
    Chicken aroma 1.0 g 1.0 g 1.0 g 1.0 g
    “Green leek” spice 2.0 g 2.0 g 2.0 g 2.0 g
    mixture in powder
    form
    “Boiled onion” spice 0.6 g 0.6 g 0.6 g 0.6 g
    mixture
    “Vegetable stock” 0.3 g 0.3 g 0.3 g 0.3 g
    yeast-spice mixture
    in powder form
    Curcuma extract 0.07 g 0.07 g 0.07 g 0.07 g
    Compound of the 0.003 g 0.03 g 0.30 g
    Formula (IVc)
  • 5 g of the respective powder mixture were added in each case to 100 ml of water so as to obtain a ready-to-serve soup.
  • In the evaluation by a panel of trained testers the comparison preparation A and the preparation C according to the invention were awarded the same scores. In the case of the preparation B according to the invention the umami taste (and mouthfeel) were described as recognizable, but less strong compared to the preparations A and C. The preparation D according to the invention was judged to have a very pronounced umami taste (and mouthfeel) and was awarded a much higher score than the preparations A and C.
  • Application Example 2 Instant Soup, Chicken Soup with Noodles Type
  • Preparation B Preparation C Preparation D
    Comparison according to according to according to
    Constituent Preparation A the invention the invention the invention
    Starch 16 g 17.2 g 17.2 g 17.2 g
    Cooking salt 7 g 7 g 7 g 7 g
    Refined sucrose 3.2 g 3.2 g 3.2 g 3.2 g
    Sodium glutamate 3.2 g
    Sodium inosinate/ 0.8 g 0.8 g 0.8 g 0.8 g
    sodium guanylate
    in the ratio 1:1
    Acid-hydrolysed 8.0 g 8.0 g 8.0 g 8.0 g
    vegetable protein
    Powdered fat 2.0 g 2.0 g 2.0 g 2.0 g
    Spray-dried 1.0 g 1.0 g 1.0 g 1.0 g
    vegetable fat
    Freeze-dried 2.0 g 2.0 g 2.0 g 2.0 g
    chicken meat, in
    small pieces
    Soup noodles 32.0 g 33.0 g 33.0 g 33.0 g
    Maltodextrin 12.16 g 13.157 g 13.13 g 12.86 g
    Freeze-dried 4.6 g 4.6 g 4.6 g 4.6 g
    Chinese
    vegetables
    Chicken aroma 8.0 g 8.0 g 8.0 g 8.0 g
    Food colouring 0.04 g 0.04 g 0.04 g 0.04 g
    agent riboflavin
    Compound of the 0.003 g 0.03 g 0.3 g
    Formula (IVc)
  • 4.6 g of the respective powder mixture were boiled for 10 minutes in in each case 100 ml of water in order to obtain a ready-to-serve soup.
  • In the evaluation by a panel of trained testers the comparison preparation A and the preparation C according to the invention were awarded the same scores. In the case of the preparation B according to the invention the umami taste (and mouthfeel) were described as recognizable, but less strong compared to the preparations A and C. The preparation D according to the invention was judged to have a very pronounced umami taste (and mouthfeel) and was awarded a much higher score than the preparations A and C.
  • Application Example 3 “Pepper” Type Spice Mixture
  • Preparation B Preparation C Preparation D
    Comparison according to according to according to
    Constituent Preparation A the invention the invention the invention
    Milk protein 0.8 g 0.8 g 0.8 g 0.8 g
    Carob seed flour 2.0 g 2.0 g 2.0 g 2.0 g
    Maize (corn) starch 25.0 g  26.994 g   26.94 g  26.4 g 
    Cooking salt 14.0 g  15.0 g  15.0 g  15.0 g 
    Paprika powder 12.0 g  13.0 g  13.0 g  13.0 g 
    Tomato powder 12.0 g  13.0 g  13.0 g  13.0 g 
    Sucrose 4.0 g 4.0 g 4.0 g 4.0 g
    Garlic powder 0.5 g 0.5 g 0.5 g 0.5 g
    Hardened 8.0 g 8.0 g 8.0 g 8.0 g
    vegetable fat
    Powdered fat 10.0 g  11.0 g  11.0 g  11.0 g 
    Sodium glutamate 6.0 g
    Foodstuff colouring 2.0 g 2.0 g 2.0 g 2.0 g
    agent Red beetroot
    and Paprika
    “Pepper” type 2.0 g 2.0 g 2.0 g 2.0 g
    aroma
    “Pizza” type 1.2 g 1.2 g 1.2 g 1.2 g
    aroma
    “Tomato” type 0.4 g 0.4 g 0.4 g 0.4 g
    aroma
    Extract of black 0.1 g 0.1 g 0.1 g 0.1 g
    pepper
    Compound of the 0.006 g  0.06 g  0.6 g
    Formula (IVc)
  • 1.7 g of each of the preparations A, B, C and D were in each case uniformly sprinkled over 100 g of pork neck cutlets and pan-fried. In the evaluation by a panel of trained testers the comparison preparation A and the preparation C according to the invention were awarded the same score. With the preparation B according to the invention the umami taste (mouthfeel) was described as recognizable, but not as pronounced as in the case of the preparations A and C. The preparation D according to the invention was judged to have a very pronounced umami taste (mouthfeel) and was awarded a much higher score than the preparations A and C.
  • Application Example 4 Tomato Ketchup
  • Preparation B Preparation C
    Comparison according to according to
    Constituent Preparation A the invention the invention
    Sodium glutamate  6 g
    Cooking salt  2 g  2 g  2 g
    Starch, Farinex WM 55  1 g  1 g  1 g
    Sucrose 12 g 12 g 12 g
    Tomato concentrate ×2 36 g 36 g 36 g
    Glucose syrup 80 Brix 18 g 18 g 18 g
    Brandy vinegar 10%  7 g  7 g  7 g
    Water 18 g 23.8 g   23.5 g  
    Compound of the Formula 0.2 g  0.5 g 
    (P1) & (P2) in the ratio 3:2
  • The ingredients are mixed in the specified order and the ready ketchup is homogenized by means of a stirrer, filled in bottles and sterilized.
  • Application Example 5 Bouillon
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Constituent preparation A Preparation B according to the invention according to the invention
    Powdered fat  8.77 g  8.77 g  8.77 g  8.77 g
    Sodium  8.77 g    5 g    5 g
    glutamate
    Powdered yeast 12.28 g 12.28 g 12.28 g 12.28 g
    extract
    Cooking salt 29.83 g 29.83 g 29.83 g 29.83 g
    Maltodextrin 37.28 g 37.28 g 37.28 g 37.28 g
    Natural  3.07 g  3.07 g  3.07 g  3.07 g
    vegetable
    extract
    Compound of  0.05 g  0.12 g
    the Formula
    (IVc)
  • 15 g of the respective powder mixture were added in each case to 1000 ml of hot water. For the evaluation the preparations were evaluated by 5 to 8 testers and the umami taste was awarded a point score ranging from 0 (no detectable umami taste) to 9 (extremely pronounced umami taste). The aqueous comparison solutions containing only sodium glutamate listed in the following table were used as reference samples for the umami detection.
  • sodium glutamate in %
    0 0.03 0.05 0.07 0.09 0.11 0.12 0.13 0.14 0.15
    Intensity 0 1 2 3 4 5 6 7 8 9
  • Each preparation to be evaluated was tested individually against the comparison solutions of the reference series.
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Preparation A Preparation B according to the invention according to the invention
    Umami taste 3.4 ± 0.8 1.9 ± 0.7 3.0 ± 0.8 3.2 ± 0.6
    (0-9)
  • Application Example 6 Spice Mixture for Potato Crisps
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Constituent Preparation A Preparation B according to the invention according to the invention
    Sodium 3.50 g   2 g   2 g
    glutamate
    Cheese powder 10.00 g  10.00 g  10.00 g  10.00 g 
    Garlic powder 2.00 g 2.00 g 2.00 g 2.00 g
    Whey powder 38.86 g  38.86 g  38.86 g  38.86 g 
    Spice extract oil 0.20 g 0.20 g 0.20 g 0.20 g
    Paprika powder 9.80 g 9.80 g 9.80 g 9.80 g
    Cooking salt 21.00 g  21.00 g  21.00 g  21.00 g 
    Tomato powder 9.00 g 9.00 g 9.00 g 9.00 g
    Dry aroma 2.50 g 2.50 g 2.50 g 2.50 g
    Silicon dioxide 0.02 g 0.02 g 0.02 g 0.02 g
    Vegetable oil 0.02 g 0.02 g 0.02 g 0.02 g
    Onion powder 3.00 g 3.00 g 3.00 g 3.00 g
    Cream aroma 0.03 g 0.03 g 0.03 g 0.03 g
    concentrate
    Cheese aroma 0.03 g 0.03 g 0.03 g 0.03 g
    Tomato aroma 0.04 g 0.04 g 0.04 g 0.04 g
    concentrate
    Spray-dried 1.40 g 2.70 g
    composition
    according to
    Example 1
  • 6 g of the spice mixture were sprinkled on 94 g of potato crisps. The evaluation of the umami taste was carried out similarly to Application Example 1.
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Preparation A Preparation B according to the invention according to the invention
    Umami taste 3.4 ± 0.9 2.4 ± 0.6 3.5 ± 0.6 3.4 ± 0.7
    (0-9)
  • Application Example 7 White Sauce
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Constituent Preparation A Preparation B according to the invention according to the invention
    Maltodextrin 26.28 g  26.28 g  26.28 g  26.28 g 
    Cooking salt 7.50 g 7.50 g 7.50 g 7.50 g
    Sodium 2.00 g 0.80 g 0.80 g
    glutamate
    Vegetable fat 5.00 g 5.00 g 5.00 g 5.00 g
    White pepper 0.02 g 0.02 g 0.02 g 0.02 g
    Onion powder 1.50 g 1.50 g 1.50 g 1.50 g
    Pre-gelatinized 30.00 g  30.00 g  30.00 g  30.00 g 
    corn starch
    Powdered fat 27.70 g  27.70 g  27.70 g  27.70 g 
    Spray-dried 1.00 g 1.80 g
    composition
    according to
    Example 1.2
  • 90 g of the sauce mixture were added to 1000 ml of hot water and vigorously stirred with a whisk. The evaluation of the umami taste was carried out in a similar way to Application Example 1.
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Preparation A Preparation B according to the invention according to the invention
    Umami taste 3.5 ± 0.7 2.3 ± 0.5 3.5 ± 1.0 3.6 ± 0.6
    (0-9)
  • Application Example 8 Brown Sauce
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Constituent Preparation A Preparation B according to the invention according to the invention
    Starch 40.00 g  40.00 g  40.00 g  40.00 g 
    Maltodextrin 33.10 g  33.10 g  33.10 g  33.10 g 
    Cooking salt 6.00 g 6.00 g 6.00 g 6.00 g
    Spray-dried sugar 5.00 g 5.00 g 5.00 g 5.00 g
    coloring
    Yeast extract 3.00 g 3.00 g 3.00 g 3.00 g
    powder
    Sodium glutamate 2.00 g 1.30 g 1.30 g
    Sugar 0.50 g 0.50 g 0.50 g 0.50 g
    Powdered fat 5.00 g 5.00 g 5.00 g 5.00 g
    Tomato powder 3.00 g 3.00 g 3.00 g 3.00 g
    Natural vegetable 1.00 g 1.00 g 1.00 g 1.00 g
    extract
    Onion extract 0.30 g 0.30 g 0.30 g 0.30 g
    Pepper extract 0.10 g 0.10 g 0.10 g 0.10 g
    Dry aroma 1.00 g 1.00 g 1.00 g 1.00 g
    Spray-dried 0.70 g 2.00 g
    composition
    according to
    Example 1.2
  • 90 g of the sauce mixture were added to 1000 ml of hot water and vigorously stirred with a whisk. The evaluation of the umami taste was carried out in a similar way to Application Example 1.
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Preparation A Preparation B according to the invention according to the invention
    Umami taste 5.2 ± 1.0 3.7 ± 1.3 5.1 ± 1.2 4.8 ± 1.3
    (0-9)
  • Application Example 9 Tomato Soup
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Constituent Preparation A Preparation B according to the invention according to the invention
    Water 50.65 g  50.65 g  50.65 g  50.65 g 
    Vegetable oil 5.50 g 5.50 g 5.50 g 5.50 g
    Tomato paste 24.00 g  24.00 g  24.00 g  24.00 g 
    Cream 1.05 g 1.05 g 1.05 g 1.05 g
    Sugar 2.00 g 2.00 g 2.00 g 2.00 g
    Cooking salt 1.70 g 1.70 g 1.70 g 1.70 g
    Sodium 0.40 g 0.25 g 0.25 g
    glutamate
    Wheat flour 5.50 g 5.50 g 5.50 g 5.50 g
    Starch 1.20 g 1.20 g 1.20 g 1.20 g
    Chopped 8.00 g 8.00 g 8.00 g 8.00 g
    tomatoes
    Spray-dried 0.20 g 0.40 g
    composition
    according to
    Example 1.2
  • The solid ingredients were weighed out, mixed, and added to the water. The vegetable oil was poured in and the tomato paste was added. The mixture was boiled while stirring. The evaluation of the umami taste was carried out in a similar way to Application Example 1.
  • Sodium glutamate- Sodium glutamate- Sodium glutamate-
    Comparison reduced Comparison reduced Preparation C free Preparation D
    Preparation A Preparation B according to the invention according to the invention
    Umami taste 5.2 ± 0.8 3.3 ± 0.9 5.6 ± 1.0 5.7 ± 1.2
    (0-9)
  • Application Example 10 Use in a Sugar-Free Chewing Gum
  • Part 1 Constituent Amount in wt. %
    A Chewing gum base, “Jagum T” Company 30.00
    B Powdered sortibol 39.00
    Isomalt ® (Palatinit GmbH) 9.50
    Xylitol 2.00
    Mannitol 3.00
    Aspartam ® 0.10
    Acesulfam ® K 0.10
    Emulgum ® (Colloides Naturels, Inc.) 0.30
    C Sorbitol, 70% 14.00
    Glycerol 1.00
    D Aroma composition containing 0.1 wt. % 1
    (2E,4E)-deca-2,4-dienoic acid isobutyl-
    amide and 10 wt. % of a mixture of the
    compounds of the Formulae (P1) & (P2) in
    a 3:2 ratio
  • Parts A to D were mixed and intensively kneaded. The raw composition can be processed for example in the form of thin strips into ready-to-use chewing gum.
  • Specific Embodiments
  • Specific embodiment one comprises use of a compound of the Formula (I)
  • Figure US20100189863A1-20100729-C00033
      • wherein:
      • R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
      • with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least one further of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
      • Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl;
      • and
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms as a food flavor substance.
    • Specific embodiment two comprises use according to specific embodiment one, wherein three, four, five or six of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 denote hydrogen.
    • Specific embodiment three comprises use according to one of the preceding specific embodiments, wherein the total number of carbon atoms of the compound of the Formula (I) is not greater than 25, preferably not greater than 20.
    • Specific embodiment four comprises use according to one of the preceding specific embodiments, wherein the compound of the Formula (I) is a compound of the Formula (II),
  • Figure US20100189863A1-20100729-C00034
      • wherein;
      • R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms,
      • with the proviso that at least one of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen,
      • wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms,
      • Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl,
      • and
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
  • Specific embodiment five comprises use according to one of the preceding specific embodiments, wherein:
      • Y1 and Y2 denote independently of one another hydrogen or methyl, and preferably both denote hydrogen.
    • Specific embodiment six comprises use according to one of the preceding specific embodiments, wherein the compound of the Formula (I)
      • is a compound of the formula (III)
      • wherein:
  • Figure US20100189863A1-20100729-C00035
      • R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
      • or
        • is a compound of the Formula (IV)
  • Figure US20100189863A1-20100729-C00036
      • wherein:
      • R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
        wherein in Formula (III) and Formula (IV):
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
    • Specific embodiment seven comprises use according to specific embodiment six, wherein R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV)
      • denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl or 1,2,2-trimethyl-propyl,
      • or
      • denote jointly a —CH2—, —C(CH3)2—, CH2CH2— or CH═CH— bridge.
    • Specific embodiment eight comprises use according to specific embodiment six or seven, wherein:
  • Ra and Rb denote independently of one another hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methyl-butyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethyl-propyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methyl-pentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethyl-butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl
      • or
      • an alkenyl radical with 2 to 6 C atoms
      • or
      • a cycloalkyl radical with 3 to 6 C atoms,
        wherein preferably Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
  • Specific embodiment nine comprises use according to one of specific embodiment six to eight, wherein:
    • Ra denotes hydrogen and
    • Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methyl-butyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methyl-pentyl, 2-methylpentyl, 3-methylpentyl, 4-methyl-pentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethyl-butyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl,
      • or
      • an alkenyl radical with 2 to 6 C atoms
      • or
      • a cycloalkyl radical with 3 to 6 atoms,
        wherein preferably Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl
        or
        Ra and Rb both denote methyl.
    • Specific embodiment ten comprises use according to one of specific embodiments six to nine, wherein the compound of the Formula (IV) is a compound of the Formula (IVa), preferably one of the two enantiomeric compounds of the Formula (Iva)
  • Figure US20100189863A1-20100729-C00037
    • Specific embodiment eleven comprises use according to one of specific embodiments six to ten, wherein the compound of the Formula (IV) is a compound of the Formula (IVc).
    • Specific embodiment twelve comprises use according to one of the specific embodiments one to nine, wherein the compound of the Formula (IV) is a compound of the Formula (E1) and/or (E2)
  • Figure US20100189863A1-20100729-C00038
      • and/or
      • a compound of the Formula (B1) and/or (B2)
  • Figure US20100189863A1-20100729-C00039
      • and/or
      • a compound of the Formula (P1) and/or (P2)
  • Figure US20100189863A1-20100729-C00040
      • and/or
      • a compound of the Formula (P3) and/or (P4)
  • Figure US20100189863A1-20100729-C00041
      • and/or
      • a compound of the Formula (H1) and/or (H2)
  • Figure US20100189863A1-20100729-C00042
    • Specific embodiment thirteen comprises use of a compound of the Formulae (I), (II), (III) or (IV) as defined in one of the preceding specific embodiments, for producing, modifying or intensifying an umami taste.
    • Specific embodiment fourteen comprises a composition suitable for consumption, containing or consisting of
      • a taste-active amount of one or more compounds of the Formula (I), (II), (III) or (IV) as defined in one of specific embodiments one to twelve, as well as
      • one or more further ingredients suitable for consumption.
    • Specific embodiment fifteen comprises a composition according to specific embodiment fourteen, wherein the further ingredients are:
      • solid carrier substances or
      • solid carrier substances and aroma compositions, or
      • water, an oily phase, one or more W/O emulsifiers, optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
    • Specific embodiment sixteen comprises a composition according to specific embodiment fifteen, wherein the further ingredients are solid carrier substances and the weight ratio of the total mass of the compounds of the Formulae (I), (II), (III) or (IV) as defined in one of specific embodiments one to twelve to the solid carrier substances is in the range from 1:10 to 1:100000, preferably in the range from 1:100 to 1:20000, particularly preferably in the range from 1:1000 to 1:5000, referred to the dry mass of the composition.
    • Specific embodiment seventeen comprises a composition according to specific embodiment fifteen, including or consisting of
      • 0.01 to 0.1 wt. % of one or more compounds of the Formulae (I), (II), (III) or (IV) as defined in one of specific embodiments one to twelve,
      • 5 to 30 wt. % of water,
      • 50 to 90 wt. % of an oily phase,
      • 0.1 to 5 wt. % of an edible W/O emulsifier, as well as
      • optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
    • 18. (i) ready-for-use or ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, including
      • a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as defined in one of specific embodiments one to twelve, or
      • a composition according to one of specific embodiments fourteen to seventeen.
    • Specific embodiment nineteen comprises ready-for-use or ready-to-eat preparation according to specific embodiment eighteen serving for nutritional or consumption purposes, comprising 0.01 ppm to 100 ppm, preferably 0.1 ppm to 50 ppm, particularly preferably 1 ppm to 30 ppm of one or more of the compounds of the Formulae (I), (II), (III) or (IV) as defined in one of the specific embodiments one to twelve, referred to the total weight of the ready-to-eat preparation.
    • Specific embodiment twenty comprises a composition, preparation or semi-finished product according to one of specific embodiments fourteen to nineteen, including in addition a substance for masking or reducing an unpleasant taste impression and/or a substance for intensifying the pleasant taste impression of a pleasantly tasting substance.
    • Specific embodiment twenty-one comprises process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
      • mixing a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as defined in one of specific embodiments one to twelve or a composition according to one of specific embodiments fourteen to seventeen or twenty with one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product, or
      • adding a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as defined in one of the specific embodiments one to twelve or a composition according to one of specific embodiments fourteen to seventeen or twenty to one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product, or
      • embedding a taste-active amount of one or more compounds of the Formulae (I), (II), (III) or (IV) as defined in one of the specific embodiments one to twelve or a composition according to one of specific embodiments fourteen to seventeen or twenty in a shell or matrix material.
    • Specific embodiment twenty-two comprises a process according to specific embodiment twenty-one, for producing, modifying or intensifying an umami taste.
    • Specific embodiment twenty-three comprises a compound of the Formula (I)
  • Figure US20100189863A1-20100729-C00043
      • wherein:
      • R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
      • with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least a further one of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
      • Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl;
      • and
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
      • with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-four comprises a compound according to specific embodiment twenty-three, wherein three, four, five or six of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 denote hydrogen,
      with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-five comprises a compound according to one of specific embodiments twenty-three and twenty-four, wherein the total number of carbon atoms of the compound of the Formula (I) is not greater than 25, and is preferably not greater than 20,
      with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-six comprises a compound according to one of specific embodiments twenty-three to twenty-five, wherein the compound of the Formula (I) is a compound of the Formula (II),
  • Figure US20100189863A1-20100729-C00044
      • wherein;
      • R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms,
      • with the proviso that at least one of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen, wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms,
      • Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl,
      • and
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
      • with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide and (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-seven comprises a compound according to one of specific embodiments twenty-three to twenty-six, wherein:
    • Y1 and Y2 denote independently of one another hydrogen or methyl, and preferably both denote hydrogen,
      with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-eight comprises a compound according to one of specific embodiments twenty-three to twenty-seven, wherein the compound of the Formula (I)
      • is a compound of the Formula (III),
  • Figure US20100189863A1-20100729-C00045
  • wherein:
      • R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
      • with the exception of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide;
        or
      • a compound of the Formula (IV)
  • Figure US20100189863A1-20100729-C00046
      • wherein:
      • R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or are covalently bonded to one another,
      • wherein in Formula (III) and Formula (IV):
      • Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
      • with the exception of the compounds selected from the group consisting of:
      • (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment twenty-nine comprises a compound according to specific embodiment twenty-eight, wherein R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV)
      • denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methyl-butyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethyl-propyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl or 1,2,2-trimethylpropyl,
        or
        together denote a —CH2—, —C(CH3)2—, CH2CH2— or CH═CH— bridge,
        with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment thirty comprises a compound according to one of specific embodiment twenty-eight or twenty-nine, wherein:
    • Ra and Rb denote independently of one another hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethyl-propyl and 1,2,2-trimethylpropyl
      or
      an alkenyl radical with 2 to 6 C atoms
      or
      a cycloalkyl radical with 3 to 6 C atoms, wherein preferably Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl
      with the exception of the compounds selected from the group consisting of:
      • 2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
    • Specific embodiment thirty-one comprises a compound according to one of specific embodiments twenty-eight to thirty, wherein:
    • Ra denotes hydrogen, and
    • Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec.-butyl, tert.-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl,
      • or
      • an alkenyl radical with 2 to 6 C atoms
      • or
        a cycloalkyl radical with 3 to 6 atoms, preferably wherein preferably Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
        or
        Ra and Rb both denote methyl.
    • Specific embodiment thirty-two comprises a compound according to one of specific embodiments twenty-eight to thirty-one, wherein the compound of the Formula (IV) is a compound of the Formula (IVa), preferably one of the two enantiomeric compounds of the Formula (IVa)
  • Figure US20100189863A1-20100729-C00047
    • Specific embodiment thirty-three comprises a compound according to one of specific embodiments twenty-eight to thirty-two, wherein the compound of the Formula (IV) is a compound of the Formula (IVc)
  • Figure US20100189863A1-20100729-C00048
    • Specific embodiment thirty-four comprises a compound according to one of specific embodiments twenty-eight to thirty, wherein the compound of the Formula (IV) is a compound of the Formula (E1) and/or (E2)
  • Figure US20100189863A1-20100729-C00049
      • and/or (B1) and/or (B2)
  • Figure US20100189863A1-20100729-C00050
      • and/or (P1) and/or (P2)
  • Figure US20100189863A1-20100729-C00051
      • and/or (P3) and/or (P4)
  • Figure US20100189863A1-20100729-C00052
      • and/or (H1) and/or (H2)
  • Figure US20100189863A1-20100729-C00053
    • Specific embodiment thirty-five comprises a process for the production of a compound of the Formulae (IVa) or (IVc) as defined in one of specific embodiments thirty-two or thirty-three, comprising the following steps:
      • Reacting a compound of the Formula (V)
  • Figure US20100189863A1-20100729-C00054
      • with a compound capable of forming a carbene, whereby a compound of the Formula (VI) is formed
  • Figure US20100189863A1-20100729-C00055
      • wherein: Rc denotes alkyl, preferably ethyl,
      • saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
  • Figure US20100189863A1-20100729-C00056
      • conversion of the compound of the Formula (VII) to the corresponding acid chloride and subsequent reaction of the acid chloride with a compound of the Formula NH2—Rb,
        wherein R1, R7 and Rb have the meanings given above.
    • Specific embodiment thirty-six comprises a process for the production of a compound of the Formula
      • (i) (E1) and/or (E2)
      • (ii) (B1) and/or (B2)
      • (iii) (P1), (P2), (P3) and/or (P4)
      • (iv) (H1) and/or (H2)
      • as defined in specific embodiment thirty-four, comprising the following steps:
      • reacting a compound of the Formula (V)
  • Figure US20100189863A1-20100729-C00057
      • with a compound capable of forming a carbene, whereby a compound of the Formula (VI) is formed
  • Figure US20100189863A1-20100729-C00058
      • wherein: Rc denotes alkyl, preferably ethyl,
      • saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
  • Figure US20100189863A1-20100729-C00059
      • conversion of the compound of the Formula (VII) to the corresponding acid chloride and subsequent reaction of the acid chloride with a compound of the Formula NH2—Rb,
      • wherein R1 denotes methyl
        • R7 denotes isopropyl and
        • Rb denotes (i) ethyl
          • (ii) cyclobutyl
          • (iii) cyclopentyl or
          • (iv) cyclohexyl.

Claims (51)

1. A method of flavoring food, comprising adding a compound of the Formula (I)
Figure US20100189863A1-20100729-C00060
wherein:
R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least one further of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl;
and
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms as a food flavor substance.
2. The method according to claim 1, wherein three, four, five or six of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 denote hydrogen.
3. The method according to claim 1, wherein the total number of carbon atoms of the compound of the Formula (I) is not greater than 25.
4. The method according to claim 1, wherein the compound of the Formula (I) is a compound of the Formula (II),
Figure US20100189863A1-20100729-C00061
wherein;
R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms,
with the proviso that at least one of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen,
wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms,
Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl, and
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
5. The method according to claim 1, wherein:
Y1 and Y2 denote independently of one another hydrogen or methyl.
6. The method according to claim 1, wherein the compound of the Formula (I)
is a compound of the formula (III)
wherein:
Figure US20100189863A1-20100729-C00062
R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
or
is a compound of the Formula (IV)
Figure US20100189863A1-20100729-C00063
wherein:
R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
wherein in Formula (III) and Formula (IV):
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms.
7. The method according to claim 6, wherein R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV)
denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl or 1,2,2-trimethyl-propyl,
or
denote jointly a —CH2—, —C(CH3)2—, CH2CH2— or CH═CH— bridge.
8. The method according to claim 6, wherein:
Ra and Rb denote independently of one another hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methyl-butyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethyl-propyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methyl-pentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethyl-butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl
or
an alkenyl radical with 2 to 6 C atoms
or
a cycloalkyl radical with 3 to 6 C atoms.
9. The method according to claim 6, wherein:
Ra denotes hydrogen and
Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methyl-butyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methyl-pentyl, 2-methylpentyl, 3-methylpentyl, 4-methyl-pentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethyl-butyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl,
or
an alkenyl radical with 2 to 6 C atoms
or
a cycloalkyl radical with 3 to 6 atoms.
10. The method according to claim 6, wherein the compound of the Formula (IV) is a compound of the Formula (IVa).
11. The method according to claim 6, wherein the compound of the Formula (IV) is a compound of the Formula (IVc).
12. The method according to claim 1, wherein the compound of the Formula (IV) is a compound of the Formula (E1) and/or (E2)
Figure US20100189863A1-20100729-C00064
and/or
a compound of the Formula (B1) and/or (B2)
Figure US20100189863A1-20100729-C00065
and/or
a compound of the Formula (P1) and/or (P2)
Figure US20100189863A1-20100729-C00066
and/or
a compound of the Formula (P3) and/or (P4)
Figure US20100189863A1-20100729-C00067
and/or
a compound of the Formula (H1) and/or (H2)
Figure US20100189863A1-20100729-C00068
13. A method for producing, modifying or intensifying an umami taste comprising adding a compound of the Formula (I) as defined in claim 1.
14. A composition suitable for consumption, containing or consisting of
a taste-active amount of one or more compounds of the Formula (I) as defined in claim 1, as well as
one or more further ingredients suitable for consumption.
15. The composition according to claim 14, wherein the further ingredients are:
solid carrier substances or
solid carrier substances and aroma compositions, or
water, an oily phase, one or more W/O emulsifiers, optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
16. The composition according to claim 15, wherein the further ingredients are solid carrier substances and the weight ratio of the total mass of the compounds of the Formula (I) to the solid carrier substances is in the range from 1:10 to 1:100000, referred to the dry mass of the composition.
17. The composition according to claim 15, including or consisting of
0.01 to 0.1 wt. % of one or more compounds of the Formula (I),
5 to 30 wt. % of water,
50 to 90 wt. % of an oily phase,
0.1 to 5 wt. % of an edible W/O emulsifier, as well as
optionally one or more antioxidants and optionally one or more substances for intensifying an antioxidative action.
18. An (i) ready-for-use or ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, including a taste-active amount of one or more compounds of the Formula (I) as defined in claim 1.
19. A ready-for-use or ready-to-eat preparation according to claim 18 serving for nutritional or consumption purposes, comprising 0.01 ppm to 100 ppm of one or more of the compounds of the Formula (I), referred to the total weight of the ready-to-eat preparation.
20. A composition according to claim 14, including in addition a substance for masking or reducing an unpleasant taste impression and/or a substance for intensifying the pleasant taste impression of a pleasantly tasting substance.
21. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
mixing a taste-active amount of one or more compounds of the Formula (I) as defined in claim 1 with one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product.
22. A process according to claim 21, for producing, modifying or intensifying an umami taste.
23. A compound of the Formula (I)
Figure US20100189863A1-20100729-C00069
wherein:
R1, R2, R3, R4, R5, R6, R7 and R8 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms,
with the proviso that at least one of the radicals R1, R2, R7 and R8 and at least a further one of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 are not hydrogen, wherein independently of one another also two of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 can together denote a bridge with one or more bridge C atoms;
Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl;
and
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
24. A compound according to claim 23, wherein three, four, five or six of the radicals R1, R2, R3, R4, R5, R6, R7 and R8 denote hydrogen, with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
25. A compound according to claim 23, wherein the total number of carbon atoms of the compound of the Formula (I) is not greater than 25,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
26. A compound according to claim 23, wherein the compound of the Formula (I) is a compound of the Formula (II),
Figure US20100189863A1-20100729-C00070
wherein;
R1, R3, R5 and R7 denote in each case independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms or an alkenyl radical with 2 to 6 C atoms,
with the proviso that at least one of the radicals R1 and R7 and a further one of the radicals R1, R3, R5 and R7 are not hydrogen,
wherein independently of one another also two of the radicals R1, R3, R5 and R7 may jointly form a bridge with one or more bridge C atoms,
Y1 and Y2 denote independently of one another hydrogen, methyl or ethyl,
and
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide and (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide.
27. A compound according to claim 23, wherein:
Y1 and Y2 denote independently of one another hydrogen or methyl,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide; (1R,2R,4R,7R)-4,8,8-trimethyltricyclo[5.1.0.02,4]octane-3-carboxylic acid amide; 2,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide and 4,7,7-trimethyltricyclo[4.1.1.02,4]octane-3-carboxylic acid amide.
28. A compound according to claim 23, wherein the compound of the Formula (I)
is a compound of the Formula (III),
Figure US20100189863A1-20100729-C00071
wherein:
R1 and R5 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or jointly denote a bridge with one or more bridge C atoms,
with the exception of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide;
or
a compound of the Formula (IV)
Figure US20100189863A1-20100729-C00072
wherein:
R1 and R7 denote independently of one another in each case an alkyl radical with 1 to 6 C atoms or are covalently bonded to one another,
wherein in Formula (III) and Formula (IV):
Ra and Rb denote independently of one another hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms or a cycloalkyl radical with 3 to 6 C atoms,
with the exception of the compounds selected from the group consisting of:
(2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
29. A compound according to claim 28, wherein R1 and R5 in Formula (III) as well as R1 and R7 in Formula (IV)
denote independently of one another in each case methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methyl-butyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethyl-propyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl or 1,2,2-trimethylpropyl,
or
together denote a —CH2—, —C(CH3)2—, CH2CH2— or CH═CH— bridge,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
30. A compound according to claim 28, wherein:
Ra and Rb denote independently of one another hydrogen or an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethyl-propyl and 1,2,2-trimethylpropyl
or
an alkenyl radical with 2 to 6 C atoms
or
a cycloalkyl radical with 3 to 6 C atoms,
with the exception of the compounds selected from the group consisting of:
2,4-dimethylbicyclo[4.1.0]heptane-7-carboxylic acid amide; (2S,5R)-2-isopropyl-5-methylbicyclo[4.1.0]heptane-7-carboxylic acid amide and (exo) (1R,2S,4S,5S)-tricyclo[3.2.1.02,4]octane-3-carboxylic acid amide.
31. A compound according to claim 28, wherein:
Ra denotes hydrogen, and
Rb denotes an alkyl radical with 1 to 6 C atoms, selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, 1,1,2-trimethylpropyl and 1,2,2-trimethylpropyl,
or
an alkenyl radical with 2 to 6 C atoms
or
a cycloalkyl radical with 3 to 6 atoms,
or
Ra and Rb both denote methyl.
32. A compound according to claim 28, wherein the compound of the Formula (IV) is a compound of the Formula (IVa),
Figure US20100189863A1-20100729-C00073
33. A compound according to claim 28, wherein the compound of the Formula (IV) is a compound of the Formula (IVc)
Figure US20100189863A1-20100729-C00074
34. A compound according to claim 28, wherein the compound of the Formula (IV) is a compound of the Formula (E1) and/or (E2)
Figure US20100189863A1-20100729-C00075
and/or (B1) and/or (B2)
Figure US20100189863A1-20100729-C00076
(B1) (B2)
and/or (P1) and/or (P2)
Figure US20100189863A1-20100729-C00077
and/or (P3) and/or (P4)
Figure US20100189863A1-20100729-C00078
and/or (H1) and/or (H2)
Figure US20100189863A1-20100729-C00079
35. A process for the production of a compound of the Formula (IVa) as defined in claim 32, comprising the following steps:
Reacting a compound of the Formula (V)
Figure US20100189863A1-20100729-C00080
with a compound capable of forming a carbene, whereby a compound of the Formula (VI) is formed
Figure US20100189863A1-20100729-C00081
wherein: Rc denotes alkyl,
saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
Figure US20100189863A1-20100729-C00082
conversion of the compound of the Formula (VII) to the corresponding acid chloride and subsequent reaction of the acid chloride with a compound of the Formula NH2—Rb,
wherein R1 and R7 independently denote hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms, with the proviso that R1 and R7 are not both hydrogen, and wherein R1 and R7 can together denote a bridge with one or more bridge C atoms, and
Rb denotes hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms, or a cycloalkyl radical with 3 to 6 C atoms.
36. A process for the production of a compound of the Formula
(i) (E1) and/or (E2)
(ii) (B1) and/or (B2)
(iii) (P1), (P2), (P3) and/or (P4)
(iv) (H1) and/or (H2)
as defined in claim 34, comprising the following steps:
reacting a compound of the Formula (V)
Figure US20100189863A1-20100729-C00083
with a compound capable of forming a carbene, whereby a compound of the Formula (VI) is formed
Figure US20100189863A1-20100729-C00084
wherein: Rc denotes alkyl,
saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
Figure US20100189863A1-20100729-C00085
conversion of the compound of the Formula (VII) to the corresponding acid chloride and subsequent reaction of the acid chloride with a compound of the Formula NH2—Rb,
wherein R1 denotes methyl
R7 denotes isopropyl and
Rb denotes (i) ethyl
(ii) cyclobutyl
(iii) cyclopentyl or
(iv) cyclohexyl.
37. The method according to claim 1, wherein Y1 and Y2 denote hydrogen.
38. The method according to claim 8, wherein Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
39. The method according to claim 9, wherein Rb denotes ethyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl
or
Ra and Rb both denote methyl.
40. The method according to claim 10, wherein one of the two enantiomeric compounds of the Formula (IVa)
Figure US20100189863A1-20100729-C00086
41. The composition according to claim 16, wherein the weight ratio of the total mass of the compounds of the Formula (I) to the solid carrier substances is in the range from 1:100 to 1:20000.
42. The compound according to claim 32, wherein the compound of Formula (IV) is one of the two enantiomeric compounds of the Formula (IVa)
Figure US20100189863A1-20100729-C00087
43. The composition according to claim 41, wherein the weight ratio of the total mass of the compounds of the Formula (I) to the solid carrier substances is in the range from 1:1000 to 1:5000.
44. An (i) ready-for-use or ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, including a composition according to claim 14.
45. The preparation or product of claim 19, wherein the one or more of the compounds of the Formula (I) are 0.1 ppm to 50 ppm.
46. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
mixing a taste-active amount of a composition according to claim 14 with one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product.
47. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
adding a taste-active amount of one or more compounds of the Formula (I) as defined in claim 1 to one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product.
48. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
adding a taste-active amount of a composition according to claim 14 to one or more further ingredients of the (i) ready-to-eat preparation or of the (ii) semi-finished product.
49. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
embedding a taste-active amount of one or more compounds of the Formula (I) as defined in claim 1 in a shell or matrix material.
50. A process for producing, modifying or intensifying a taste in a (i) ready-to-eat preparation or (ii) semi-finished product serving for nutritional or consumption purposes, comprising the following step:
embedding a taste-active amount of a composition according to claim 14 in a shell or matrix material.
51. A process for the production of a compound of the Formula (IVc) as defined in claim 33, comprising the following steps:
Reacting a compound of the Formula (V)
Figure US20100189863A1-20100729-C00088
with a compound capable of forming a carbene, whereby a compound of the Formula (VI) is formed
Figure US20100189863A1-20100729-C00089
wherein: Rc denotes alkyl,
saponification of the compound of the Formula (VI) to form a compound of the Formula (VII)
Figure US20100189863A1-20100729-C00090
conversion of the compound of the Formula (VII) to the corresponding acid chloride and subsequent reaction of the acid chloride with a compound of the Formula NH2—Rb,
wherein R1 and R7 independently denote hydrogen, an alkyl radical with 1 to 6 C atoms, or an alkenyl radical with 2 to 6 C atoms, with the proviso that R1 and R7 are not both hydrogen, and wherein R1 and R7 can together denote a bridge with one or more bridge C atoms, and
Rb denotes hydrogen, an alkyl radical with 1 to 6 C atoms, an alkenyl radical with 2 to 6 C atoms, or a cycloalkyl radical with 3 to 6 C atoms.
US12/445,842 2006-10-18 2007-10-18 Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances Active 2029-11-25 US8487133B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/445,842 US8487133B2 (en) 2006-10-18 2007-10-18 Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82995806P 2006-10-18 2006-10-18
US12/445,842 US8487133B2 (en) 2006-10-18 2007-10-18 Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances
PCT/EP2007/061171 WO2008046895A1 (en) 2006-10-18 2007-10-18 Substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances

Publications (2)

Publication Number Publication Date
US20100189863A1 true US20100189863A1 (en) 2010-07-29
US8487133B2 US8487133B2 (en) 2013-07-16

Family

ID=38919192

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/445,842 Active 2029-11-25 US8487133B2 (en) 2006-10-18 2007-10-18 Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances

Country Status (4)

Country Link
US (1) US8487133B2 (en)
EP (1) EP2079322A1 (en)
CN (1) CN101528060A (en)
WO (1) WO2008046895A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013135511A1 (en) 2012-03-12 2013-09-19 Imax Discovery Gmbh N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents
WO2022170012A1 (en) * 2021-02-08 2022-08-11 The Trustees Of Indiana University Synthesis of peg-based thiol-norbornene hydrogels with tunable hydroylitic degradation properties

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG151302A1 (en) 2004-03-17 2009-04-30 Dow Global Technologies Inc Catalyst composition comprising shuttling agent for higher olefin multi- block copolymer formation
WO2005090427A2 (en) 2004-03-17 2005-09-29 Dow Global Technologies Inc. Catalyst composition comprising shuttling agent for ethylene multi-block copolymer formation
EP2008530B1 (en) 2007-06-19 2011-01-19 Symrise AG Aroma composition for reducing or suppressing unwanted bitter and astringent impressions
ATE524978T1 (en) 2008-07-30 2011-10-15 Symrise Ag COMPOSITION FOR REDUCING NACL CONTENT IN FOODS
DE102008042421A1 (en) 2008-09-26 2010-04-01 Symrise Gmbh & Co. Kg Geranylamine derivatives of oxalic acid
EP2220945B1 (en) 2008-12-11 2013-03-27 Symrise AG Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners
EP2253226B1 (en) 2009-05-15 2015-07-15 Leibniz-Institut für Pflanzenbiochemie (IPB) Use of hydroxyflavone derivatives for modifying taste
DE102009027744A1 (en) 2009-07-15 2011-01-20 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Precursor compounds of sweet receptor antagonists for the prevention or treatment of diseases
US10624372B2 (en) 2009-08-28 2020-04-21 Symrise Ag Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type
EP2298084B1 (en) 2009-08-28 2011-10-19 Symrise AG Sweetener-reduced products, aromatic mixtures for same and method of producing such products
DE102009046126A1 (en) 2009-10-28 2011-05-12 Symrise Ag Orally consumable preparation, useful e.g. in cosmetic preparation e.g. lipstick and as baked goods, comprises naturally occurring sweet-tasting substances and a root extract of Mondia whitei containing 2-hydroxy-4-methoxybenzaldehyde
EP2340719B1 (en) 2009-12-30 2014-02-19 Symrise AG Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners
ES2389709T3 (en) 2010-02-01 2012-10-30 Symrise Ag Use of 1- (2,4-dihydroxyphenyl) -3- (3-hydroxy-4-methoxyphenyl) -propan-1-one
US20110293538A1 (en) 2010-05-11 2011-12-01 Symrise Ag Use of rubusoside for reducing or suppressing certain unpleasant taste impressions
EP2517574B1 (en) 2011-04-29 2015-11-11 Symrise AG Specific vanillyl lignanes and their use as taste enhancers
ES2433004T3 (en) 2011-05-31 2013-12-05 Symrise Ag Cinnamic acid amides as spicy saporiferous substances
EP2529633B1 (en) 2011-06-01 2014-08-06 Symrise AG Orally consumed preparations comprising particular sweet tasting triterpenes and triterpene glycosides
EP2570035B1 (en) 2011-09-15 2014-06-18 Symrise AG Use of neoflavanoids for modifying taste
EP2570036B1 (en) 2011-09-15 2014-06-18 Symrise AG Use of particular neoflavanoids for reinforcing and/or generating a sweet sensory sensation
DE102011085136A1 (en) 2011-10-24 2013-04-25 Deutsches Institut für Ernährungsforschung - Stiftung des öffentlichen Rechts - Use of new or known guanidine compound or a mixture comprising of two or more guanidine compounds e.g. as flavoring agent for creating, mediating, modifying and/or amplifying a salty flavor impression of sodium chloride
DE102012214560A1 (en) 2011-12-02 2013-06-06 Symrise Ag Use of 1-3 enterodiol compounds comprising e.g. (2R,3S)-2,3-bis-(3-hydroxy-benzyl)-butane-1,4-diol for sensorially changing unpleasant taste impression, preferably bitter-, astringent- and/or metallic taste impression of bitter substance
EP2614727B1 (en) 2012-01-10 2016-09-07 Symrise AG N-Nonanoylvanillylamine as an appetite reduction agent and as a means for generating the feeling of being full and corresponding orally consumable products and method
JP2015097474A (en) * 2012-03-09 2015-05-28 味の素株式会社 seasoning
EP2873328B1 (en) 2013-11-17 2020-10-28 DMK Deutsches Milchkontor GmbH Process for the preparation of frozen pizza topped with acidified milk product with good baking properties and high freeze-thaw stability
EP2883459B1 (en) 2013-12-16 2018-04-04 Symrise AG Compositions for oral consumption
EP2915429B1 (en) 2014-03-04 2019-01-09 DMK Deutsches Milchkontor GmbH Protein mass to be used as a cheese surrogate
EP2918270A1 (en) 2014-03-12 2015-09-16 Symrise AG Derivatives of aromatic alkenoic acids for curbing appetite and enhancing mood
EP2952103B1 (en) 2014-06-05 2019-05-08 Symrise AG Component mixtures
EP2954785B1 (en) 2014-06-13 2018-06-06 Symrise AG New composition for improvement of sweet taste comprising rubusoside or alpha-glycolsylrubusoside
EP2990036B1 (en) 2014-07-30 2019-04-10 Symrise AG Hydroxyflavones for stimulating appetite
EP3078273A1 (en) 2015-04-08 2016-10-12 DMK Deutsches Milchkontor GmbH Curded milk products as base for cocktail deserts
EP3085239A1 (en) 2015-04-25 2016-10-26 DMK Deutsches Milchkontor GmbH Sterile cheese base
US10702484B2 (en) 2016-04-28 2020-07-07 Symrise Ag Use of 3-(3-hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxy-phenyl) propan-1-one
EP3451857B1 (en) 2016-05-05 2021-07-14 Symrise AG Coolant mixtures
CN109310595A (en) 2016-05-14 2019-02-05 西姆莱斯股份公司 Containing menthol flavoring formulation
EP3700352B1 (en) 2017-10-23 2021-09-22 Symrise AG Aroma composition
EP3823455A1 (en) 2018-07-16 2021-05-26 Symrise AG Composition for substituting sugar in baked goods
US20220071933A1 (en) 2019-01-18 2022-03-10 Symrise Ag Combination remedy
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
WO2021232123A1 (en) * 2020-05-22 2021-11-25 Ourofino Saude Animal Ltda Taste-masking system
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2023036404A1 (en) 2021-09-07 2023-03-16 Symrise Ag Taste balancing botanical compounds
WO2023066457A1 (en) 2021-10-19 2023-04-27 Symrise Ag Rubusoside glucosides
WO2023117119A1 (en) 2021-12-23 2023-06-29 Symrise Ag Active ingredients with sialagogue and tingling/fizzy effect, and preparations containing same
WO2023143741A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3504080A (en) * 1962-07-27 1970-03-31 Glanzstoff Ag Method of producing dimensionally - stable injection molded polyesters
US4331570A (en) * 1980-07-17 1982-05-25 International Flavors & Fragrances Inc. Carboamidoalkyl norbornanes and organoleptic use in perfumes
US4386064A (en) * 1980-03-25 1983-05-31 International Flavors & Fragrances Inc. Flavoring with carbomethoxy methyl norbornanes
US20040077617A1 (en) * 2002-10-22 2004-04-22 Bennani Youssef L. Fused cycloalkyl amides and acids and their therapeutic applications
US20040209859A1 (en) * 2002-10-22 2004-10-21 Bennani Youssef L. Fused cycloalkyl amides and acids and their therapeutic applications
US20060057268A1 (en) * 2004-09-10 2006-03-16 Dewis Mark L Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599103A1 (en) * 2003-02-26 2005-11-30 Firmenich Sa Aminoacid derivatives of dicarboxylic acids as flavor ingredients
DE10310204A1 (en) 2003-03-08 2004-09-16 Symrise Gmbh & Co. Kg Use of divanillin as a flavoring
DE102004017076A1 (en) 2004-04-07 2005-10-27 Symrise Gmbh & Co. Kg Use of gamma-aminobutyric acid for masking or reducing an unpleasant taste impression and preparations containing gamma-aminobutyric acid
EP1819238B1 (en) 2004-12-03 2009-02-18 Symrise GmbH & Co. KG Use of diacetyl trimer as an aromatic and flavouring substance
WO2006106023A1 (en) 2005-04-04 2006-10-12 Symrise Gmbh & Co. Kg Hydroxydeoxybenzoins and the use thereof to mask a bitter taste
DE602006007355D1 (en) 2005-07-05 2009-07-30 Symrise Gmbh & Co Kg HYDROXYPHENYL ALKADIONE AND ITS USE TO COVER BITTER TASTE AND / OR REINFORCE SWEET TASTE

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3504080A (en) * 1962-07-27 1970-03-31 Glanzstoff Ag Method of producing dimensionally - stable injection molded polyesters
US4386064A (en) * 1980-03-25 1983-05-31 International Flavors & Fragrances Inc. Flavoring with carbomethoxy methyl norbornanes
US4331570A (en) * 1980-07-17 1982-05-25 International Flavors & Fragrances Inc. Carboamidoalkyl norbornanes and organoleptic use in perfumes
US20040077617A1 (en) * 2002-10-22 2004-04-22 Bennani Youssef L. Fused cycloalkyl amides and acids and their therapeutic applications
US20040209859A1 (en) * 2002-10-22 2004-10-21 Bennani Youssef L. Fused cycloalkyl amides and acids and their therapeutic applications
US20060057268A1 (en) * 2004-09-10 2006-03-16 Dewis Mark L Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013135511A1 (en) 2012-03-12 2013-09-19 Imax Discovery Gmbh N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents
WO2022170012A1 (en) * 2021-02-08 2022-08-11 The Trustees Of Indiana University Synthesis of peg-based thiol-norbornene hydrogels with tunable hydroylitic degradation properties

Also Published As

Publication number Publication date
CN101528060A (en) 2009-09-09
EP2079322A1 (en) 2009-07-22
US8487133B2 (en) 2013-07-16
WO2008046895A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
US8487133B2 (en) Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances
US8871288B2 (en) Aromatic neomenthylamides as flavoring substances
US7919133B2 (en) Substituted cyclopropanecarboxylic acid (3-methyl-cyclohexyl)amide as flavoring substance
US8852664B2 (en) Neo-menthyl derivatives as flavor materials
US9144248B2 (en) Cinnamamides as savory flavorings
US8063107B2 (en) Use of trans-pellitorin as flavor substance
US8344025B2 (en) Oxalic acid derivatives and use thereof as physiological cooling active ingredients
US8420151B2 (en) Mixtures having a salty taste
US20070202188A1 (en) Use of alkene carboxlic acid n alkylamides as flavouring agents
US8273398B2 (en) Geranylamine derivates of oxalic acid
JP2008505868A (en) Use of alkoxyalkanoic acid amides and in particular novel alkoxyalkanoic acid amides as flavoring agents
WO2013135511A1 (en) N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents
JP2022550392A (en) Improvements in or relating to organic compounds
US20220304352A1 (en) Taste-modifying compounds and uses thereof
DE102011085136A1 (en) Use of new or known guanidine compound or a mixture comprising of two or more guanidine compounds e.g. as flavoring agent for creating, mediating, modifying and/or amplifying a salty flavor impression of sodium chloride
DE102006006123A1 (en) Use of alk-2-en-4-acidamide compounds e.g. as aroma materials, for producing tingling sensation or cooling effect and/or stimulation of saliva in mouth, for mouth hygiene and in oral pharmaceutical preparation

Legal Events

Date Code Title Description
AS Assignment

Owner name: SYMRISE GMBH & CO. KG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOOFT, JAN;VOSSING, TOBIAS;BACKES, MICHAEL;SIGNING DATES FROM 20090504 TO 20090505;REEL/FRAME:024203/0961

AS Assignment

Owner name: SYMRISE AG, GERMANY

Free format text: MERGER;ASSIGNOR:SYMRISE GMBH & CO. KG;REEL/FRAME:026171/0582

Effective date: 20101109

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8